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ABSTRACT
THE ROLE OF LIPOTEICHOIC ACID AND THE LEUKOCYTE INTEGRINS IN 
THE BINDING OF GROUP B STREPTOCOCCI TO MURINE PERITONEAL
MACROPHAGES
Anne R. Sloan 
University of New Hampshire, May, 1992
The macrophage has been shown to bind potentially pathogenic 
bacteria in the absence of serum components, but the mechanism is not well 
understood. The macrophage is a key component of our non-inducible 
defenses and this form of innate immunity is of particular importance for 
individuals in which the immune system may be sub-optimally functional, 
e.g., neonatal and geriatric individuals, and for sites in the body in which 
serum enhancement through opsonins is thought to be insufficient, e.g., 
lungs. To understand the mechanism by which mammalian innate host 
defenses respond to potential microbial aggression by opportunistic 
microorganisms, I developed two assays to quantify the in vitro, serum-free 
adherence of group B Streptococcus to murine peritoneal macrophages. The 
first is a modified direct microscopic assay, while die second is based upon an
enzyme-linked assay using bacterial specific antibody.
Sugar inhibition assays as well as studies with isogenic strains and 
neuraminidase-treated streptococci could not confirm a mechanism proposed 
by other investigators that macrophages recognize these streptococci by a 
lectin-like receptor for galactose. I observed that binding characteristics of the 
macrophage, such as temperature- and divalent cation- dependence, protease 
sensitivity, and enhancement by fibronectin and phorbol esters, were similar 
to those of the integrins, a heterodimeric family of leukocyte receptors. 
Monoclonal antibodies M l/70, which recognizes the a-subunit of one 
member of the family, complement receptor 3 (CR3), and M18/2, which 
recognizes the P-subunit, common to all three members, were each shown to 
reduce bacterial adherence in down-modulation, flow cytometric and soluble 
inhibition studies. Using similar approaches I have additionally shown that 
the purified streptococcal membrane phosphosugar, lipoteichoic acid, can 
inhibit the binding of these bacteria to macrophages. These results support 
roles for both lipoteichoic add and the P2 integrins in the innate recognition 
of group B streptococd by macrophages.
INTRODUCTION
Phagocytic cells in higher animals are capable of discriminating between 
foreign material and self components, as well as between self and altered self 
(47). This recognition ability is thought to have developed with the 
evolution of multicellular life forms, since primitive colonial marine species 
such as Porifera exhibit the ability to exclude non-self life forms (105). 
Concomitantly the generalized process of phagocytosis became associated with 
specialized cells in metazoans (26). Hemocytes from invertebrates have been 
shown to perform many of the functions associated with phagocytic cells in 
well-studied mammalian systems (67).
In vertebrates a highly adaptive immune system has evolved, involving 
extensive cooperation between cellular and humoral components and the 
concept of specialized recognition (84), and this facet of the host's defenses has 
been the subject of comprehensive studies. The more primitive forms of 
phagocyte recognition appear, however, to have been retained and the cells 
appear capable of recognizing foreign particulate material without the use of 
their more recently evolved receptors for the Fc component of the 
immunoglobulin molecule or the C3b component of the complement system 
(94).
The mechanisms that underlie these highly important recognition
1
2abilities of phagocytes is not fully understood. It is not known if the binding 
of a bacterium to a phagocytic cell involves complex stereospedfic receptors in 
the cell for components of the cell surface of the microorganism or whether 
the binding depends on a simpler, relatively nonspecific ability to recognize 
carbohydrate or other cell surface constituents. Such interactions may depend 
on hydrophobic molecules present in the foreign particle inserting 
themselves in the phospholipid cell membrane of the phagocytes (109).
Cell membranes contain lipids, proteins, oligosaccharides and 
polysaccharides in various combinations (91). Membrane phospholipids 
have hydrophilic polar heads that interact with water at the external and 
internal sides of the phospholipid bilayer. Their hydrophobic tails associate 
within the bilayer and are excluded from water. These molecules are capable 
of lateral movement in the membranes. Membrane proteins exist in 
hydrophilic and hydrophobic forms. The hydrophobic proteins (integral 
membrane proteins) are embedded to variable depths into the phospholipid 
bilayer and may span the membrane. In the latter situation they will have 
hydrophilic peptide sequences at either end of the molecule. Such molecules 
often have a carbohydrate chain at the external surface of the bilayer and are 
glycoproteins. Other non-structural proteins with hydrophilic properties are 
present at the external and internal surfaces of the lipid bilayer and are called 
peripheral membrane proteins.
Peripheral membrane proteins can be dissociated from integral membrane
3proteins and giycolipids by high salt concentration and chelating agents (33). 
Their removal, in contrast to the integral proteins, usually does not affect the 
structural integrity of the cell membrane. Some integral proteins can, like the 
phospholipids themselves, move laterally in the membrane. Membrane 
glycoproteins and giycolipids are arranged so that their carbohydrate residues 
are exposed at the external surface of the membrane. Many of these 
molecules are known to act as receptors for antibodies, hormones, viruses, 
and other agents. Their lateral movement can result in the formation of 
patches or caps in which their distribution is altered from a diffuse to a 
coalesced arrangement.
Microtubules together with microfilaments lie in the cytoplasm of the cell 
and control the mobility and distribution of cell surface receptors (62). The 
fact that different integral proteins and glycoproteins have considerably 
different rates of lateral movement suggests the importance of restricted 
mobility of some components so as to maintain an ordered display of patterns 
on the cell surface. Such cell-specific surface patterns could constitute an 
important mechanism for determining cell contact and recognition 
phenomena. The ability of some of these molecules to move rapidly in the 
cell membrane in response to environmental factors, such as complement or 
antibodies, enables reversible changes in the cell surface pattern to take place.
4Non-opsonin-mediated recognition o f bacteria by macrophages 
Serum factors have been shown to enhance the rate of uptake of 
microorganisms by phagocytes since the early 1900's (111). Over the years it 
has been established that the primary role of the opsonins is to provide a 
means of recognition between phagocytes and their targets, e.g., bacteria (33, 
50) in a process known as opsonophagocytosis.
Opsonophagocytosis can occur in three modes (82). In the first, only 
antibodies participate by reacting via their (Fab)2 combining sites with the 
appropriate antigenic determinants on the bacterial surface. The Fc portion of 
the coating immunoglobulin G molecule binds to the corresponding Fc 
receptors on the surface of the phagocytes, thereby bringing the microbe and 
phagocytic cell in close proximity. In the second mode, only the C3b and C3bi 
fragments of complement participate. The C3b and C3bi fragments are 
generated from C3 as a result of its activation by contact with certain microbial 
surface constituents, a process known as the alternative pathway of 
activation. C3b or C3bi attaches to the microbial surface covalently via thiol 
ester or amide bonds and to the phagocyte surface via specific receptors 
known as CR1 or CR3, respectively (50).
In the third mode, both antibody and C3b (or C3bi) participate. The 
antibody binds to the microbial surface antigens, and the antigen-antibody 
complexes thus formed activate complement, either by the classical pathway 
or the alternative pathway, following which C3b or C3bi is deposited onto the
5microbial surface. The microorganisms, which are now coated with both 
antibody and complement fragments, bind to the phagocytes via the receptors 
for both ligands. This binding is greatly enhanced over that with either 
immunoglobulin G or the fragments of C3 alone (52).
The second mode of opsonophagocytosis has been a subject of much 
interest, since it can occur in the non-immune host, and therefore serves as 
an early defense mechanism against microbial infections (25). It depends on 
the availability of complement at the site of infection, on the ability of bacteria 
to activate complement by the alternative pathway and to deposit fragments 
of C3 on their surfaces, and on the proper orientation of the cell-bound 
fragments to react with the appropriate receptors on the phagocytes. These 
conditions are not always met. Certain sites, such as the lungs (28,51) or renal 
medullae (85, 86) have low serum opsonin concentrations, which may not be 
sufficient to effectively opsonize many bacterial species. Additionally, not all 
organisms activate the alternative pathway efficiently (25,42, 66), and 
complement-deficient states have been reported during the neonatal period 
(1,15). Moreover, patients deficient in C3 can frequently cope with a variety 
of bacterial infections, irrespective of the ability of the bacteria to activate the 
alternative pathway.
Evidence from in vitro studies demonstrates that phagocytosis of bacteria 
occurs in opsonin-free media (20,33,43, 53,69,70,101), while that from in 
vivo studies shows clearance of bacteria from the lungs by alveolar
6macrophages (28, 51) or from the blood by the reticuloendothelial system of 
animals depleted of complement (11). Nonopsonic recognition between 
bacteria and phagocytes may be occurring by one or more mechansims.
Several investigators have postulated that the net surface charge or the 
hydrophobicity of particles or bacteria determines whether they can be bound 
by phagocytes (92,102), but no direct evidence for these assumptions has been 
obtained. It is still possible that nonspecific or ill-defined surface properties 
may account for the recognition by phagocytes of some particles (e.g., 
polystyrene beads). However, as pointed out by Griffin (33), recognition of 
most physiologically relevant particles must involve more specific 
mechanisms.
The role o f lectins in recognition o f microorganisms by phagocytic cells
During the last decade considerable evidence has accumulated showing 
that specific recognition by phagocytes may be accomplished by the interaction 
of carbohydrate-binding proteins, e.g., lectins, on the surface of one type of cell 
that combine with complementary sugars on the surface of another in a lock- 
and-key manner (82,83). This type of recognition, which also leads to 
phagocytosis, has been termed lectinophagocytosis (60). Lectinophagocytosis 
of bacteria can occur in two major modes. In the first, bacteria that carry 
surface lectins bind to complementary carbohydrates on the surface of the 
phagocytic cells. In the second, lectins that are integral components of the
7phagocytic cell membrane bind to carbohydrates on the bacterial surface.
Macrophages have several cell-associated lectins that have been implicated 
in microbial recognition (30). A receptor on human macrophages has been 
shown to recognize mannose-bearing pathogens and to mediate their 
internalization (24). This mannose/fucosyl receptor (MFR) recognizes 
Leishmania promastigotes and synthesis of reactive oxygen metabolites is 
triggered by adherence to this receptor (46). Human monocytes bear |}-glucan 
receptors that react with zymosan particles (19), thus providing the cells with 
the ability to detect microorganisms bearing this glycan in the absence of 
serum factors. The clearance of Klebsiella pneumoniae from the lung may be 
due to a mannosyl/N-acetyl-D-glucosaminyl receptor found on alveolar 
macrophages (7).
Rat Kupffer cells in vitro strongly bind neuraminidase-treated but not 
untreated rat erythrocytes (49). Preincubation of the macrophages with D- 
galactose and related sugars inhibits cell adherence and suggests that the 
galactose-specific lectin receptor recognizes senescent erythrocytes (79).
The Group B Streptococcus
Group B streptococci (GBS) are a major cause of neonatal meningitis and 
septicemia in this country (80). These organisms are classified into serotypes 
based on their specific capsular polysaccharides. The capsular polysaccharides 
of serotypes la, lb, II and m  have been purified and characterized (39,38,41,
840). The structure of the capsular polysaccharides for these serotypes is 
represented in Fig. 1 (44). The backbone antigen is composed of a repeating 
unit of two to five monosaccharides, depending on the serotype. Side-chain 
pD-galactose may be either exposed or be covered by a terminal sialic add.
Type II strains, which account for ~15% of all infant infections, have been 
isolated only rarely from infants with meningitis (108,110). Among GBS 
isolates from adults with meningitis, however, type II strains predominate 
(110). Of the defined capsular polysaccharides the type m  capsule is found on 
organisms most frequently isolated from neonatal infections. Although 
frequently found among the flora colonizing the vaginal tract, they seldom 
contribute to disease in the otherwise healthy adult host. During parturition, 
particularly when accompanied by premature rupture of the fetal membranes, 
GBS may be acquired by the newborn; systemic infection may follow (35).
Role o f complement receptor 3 (CR3) in host defenses
Adhesion between phagocytes and other cells is a necessary prerequisite 
for phagocytosis (103). Phagocytosis represents an important effector 
mechanism for the eradication of infectious agents and is performed 
primarily by spedalized cells of two different lineages, namely 
polymorphonudear neutrophilic granulocytes (PMN) and mononuclear 
phagocytes (Mo). To fulfill their role in host defense, PMN and Me must 
respond to specific signals that indicate the presence of infectious agents and
9Structural modifications of group B streptococcal polysaccharides 
lb __________________________________________________________





























Fig. 1. Structure of GBS serotypes with modification by neuraminidase 
treatment (2), from reference 44.
* site of cleavage by neuraminidase
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also collaborate with the elements of specific immunity. It has long been 
assumed that these cells have specific receptors for binding microorganisms 
directly, but only recently have such receptors been isolated and characterized.
The idea that a few receptors could be responsible for a wide range of 
adhesion events first arose with the discovery of a class of patients that exhibit 
recurrent life-threatening infections with gram-positive, gram-negative and 
fungal pathogens (5). These patients exhibit extreme leucocytosis but fail to 
form pus at sites of infection. In vitro experiments showed that PMN from 
these patients are defective in adhesion to C3bi-coated erythrocytes, to protein- 
coated glass or plastic surfaces (3), and to endothelial cells (34), and that failure 
to adhere results in the failure to display chemotactic responses. Thus, 
susceptibility to infection probably results both from an inability to bind and 
ingest opsonized pathogens and a failure to recruit cells to sites of infection. 
More importantly, these observations suggest that the leucocytes of patients 
fail to extravasate and are retained in the vasculature by a failure to adhere to 
endothelial cells, giving the name of leucocyte adhesion deficiency (LAD) to 
this condition. Characterization of the proteins missing from the patients' 
leucocytes have confirmed their role in adhesion to endothelium and in 
other adhesion events.
LAD is caused by a failure of leucocytes to express three related proteins, 
LFA-1, CR3 and p i50,95 of the integrin family of cell-cell and cell-matrix 
proteins (90). Each of these cell-surface glycoproteins consists of an 04 ft
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dimer composed of a 150,-190,000 Mr a  chain and a 95,000 Mr f) chain. The (3 
chain is identical in each of these three proteins (77) and has been given the 
designation CD18 by the International Workshop on Leucocyte Antigen 
Differentiation. The a  chains are structurally and antigenically distinct (113). 
The a  chains of LFA-1, CR3 and pl50,95 are termed CDlla, C D llb and CDllc, 
respectively, and CR3 is referred to as CDllb/CD18.
LAD patients are deficient in all three of these proteins because of an 
inherited defect in the (3 chain (90). Cells from LAD patients do synthesize 
normal precursors of the a  chains, but these precursors are very rapidly 
degraded and do not appear on the cell surface. Patients have recurring 
infections, often fatal in childhood unless they are corrected by bone marrow 
transplantation. In a study by Ross et al. (73), children with LAD had 
recurrent skin infections with Staphylococcus epidermidis but not yeast 
suggesting the role of CR3 and LFA-1 in the phagocytosis of unopsonized 
bacteria.
Lymphocytes express abundant LFA-1, but neither CR3 or pl50,95. PMN 
express abundant CR3, whereas LFA-1 and p i50,95 are minor but easily 
detectable components. Macrophages express large amounts of all three of 
these proteins. Expression of these proteins appears to be restricted to 
leucocytes; they have not been found on other mammalian cell types.
The first molecule shown to be deficient from LAD patients (6) had been 
previously identified as a receptor for a cell-bound fragment of complement
12
(114) and was named CR3 (complement receptor type three). CR3 has also 
been referred to as Mac-1 and Mol because it was the first phagocyte-specific 
antigen identified by monoclonal antibodies in mouse and man, respectively. 
CR3 functions as an opsonic receptor, and promotes the binding of C3bi- 
coated cells and particles by monocytes, macrophages and PMN (112,117). In 
appropriately stimulated cells, binding is followed by phagocytosis of the 
particle but does not induce reactive oxygen metabolites (21). Therefore, CR3 
provides a safe way for entry into professional phagocytes, compared to 
internalization via the Fc receptor. Most intracellular pathogens except 
viruses, have been shown to use CR3 for entry into mononuclear phagocytes. 
Examples are Legionella pneumophila (63), Mycobacterium tuberculosis (64), 
Leishmania sp. (98), and Histoplasma capsulatum (12).
CR3 requires relatively high concentrations of divalent cations (about 0.5 
mM Ca2+ and Mg2+) in order to interact effectively with ligand (112). Integrin 
a-subunits have three or four tandem repeats of a putative divalent cation- 
binding motif, and have been shown to require Ca?+ or Mg2+ for function (91). 
This behavior contrasts with that of other opsonic receptors (CR1 and FcR) 
which do not require divalent cations for binding activity. In addition, the 
binding capacity of CR3 is temperature-dependent, and is absent in cells held 
at 0°C (116), again distinguishing CR3 from other opsonic receptors (CR1 and 
FcR) which bind well at 0°C.
In the presence of serum, most pathogens are taken up via C3bi
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deposition on their surface. CR3 does not recognize either the precursor C3b, 
or the product of further cleavage C3dg (14,112,72). Binding of monomeric 
or dimeric C3bi to CR3 has not been reported, presumably because of low 
binding affinity. Studies using sheep erythrocytes coated with 104 to 105 O b i 
per cell demonstrate avid binding to CR3-bearing cells presumably because of 
multivalent interaction with the phagocytes. By analogy, it is likely that LFA- 
1 and pl50,95 also bind their targets with low affinity and that adhesion 
events mediated by these receptors are driven by multivalent interactions. A 
functional consequence of low affinity binding is the potential to reverse 
adhesion and promote detachment.
CR3 has two distinct binding sites. One is located on the a  chain and binds 
ligands such as O b i, containing the Arg-Gly-Asp (RGD) sequence. In the 
absence of O b i, microorganisms expressing a surface protein containing the 
RGD sequence could bind to CR3. For example, Bordetella pertussis, a gram- 
negative coccobadllus and the causative agent of whooping cough, has been 
shown to adhere to human macrophages in vitro. The interaction between 
macrophage CR3 and B. pertussis filamentous hemagglutinin (FHA) 
involves recognition of the RGD sequence at positions 1097-1099 in FHA (68).
The other binding site on the a  chain of CR3 has a lectin-like character 
and, for example, recognizes lipopolysaccharide (LPS) located on the outer 
leaflet of the outer membrane of Escherichia coli (103,116). Histoplasma 
capsulatum binds directly to CR3 via the lectin-like binding site (94). In
14
addition, an abundant surface glycolipid, promastigote lipophosphoglycan 
(LPG), from Leishmania has been shown to bind to the 'lectin-like-LPS' 
binding site on the a  chain of CR3 (98,77). It is possible that LPS, LPG and H. 
capsulatum display a common structure, such as a sugar phosphate, that can 
be recognized by CR3 (116).
Lipoteichoic acid as bacterial ligand for CR3 
Group B streptococci contain membrane teichoic add, lipoteichoic add 
(LTA), which is known to mediate the adherence of GBS to human 
embryonic, fetal and adult epithelial cells (55). The membrane teichoic adds 
found in gram-positive bacteria exhibit a rather uniform structure: 
polyglycerol phosphate polymers with D-alanine and saccharides as 
constituents. (107). The hydrophobic end of the molecule interads with the 
lipid bilayer of the membrane in combination with glycolipids or 
phospholipids. The hydrophilic chain of the teichoic add, located on the 
outer surface of the membrane, extends into the space between the membrane 
and cell wall. Electron microscopy of bacteria using ferritin-labeled antibodies 
to LTA have shown that the polymer extends from the outer surface of the 
membrane through the cell wall and beyond the outer boundary of the cell 
into the external environment. The length of the membrane teichoic add 
chain corresponds to the thickness of the cell wall as observed by electron 
microscopy.
15
Lipoteichoic add from group B streptococd consists of a glycerol phosphate 
chain attached to a terminal lipid residue, identical in character to a free 
glycolipid of the cytoplasmic membrane. The glycerol phosphate backbone is 
substituted with glucose (55). Results from the study of Nealon and Mattingly 
(55) indicate that the binding mechanism of LTA from GBS to human 
embryonic and fetal cells is temperature dependent and is influenced by both 
the lipid moiety and the glycerol phosphate backbone. The binding of LTA 
appears to involve a hydrophobic interaction which is dependent on the 
membrane fluidity of the human cells as well as a hydrophilic interaction of 
the glycerol phosphate backbone with spedfic receptor sites on the human 
cells. The structural similiarities of the sugar phosphate part of the LTA 
molecule with that of both LPG and LPS, which are known to be bacterial 
ligands for CR3, suggest a possible role for LTA in the adherence of GBS to 
macrophages.
CHAPTER 1
A QUANTITATIVE METHOD FOR MEASURING THE ADHERENCE OF 
GROUP B STREPTOCOCCI TO MURINE PERITONEAL EXUDATE
MACROPHAGES
Abstract
I have developed a solid phase, direct binding, enzyme-linked immuno­
sorbent assay (ELISA) to detect and quantify the adherence of group B 
streptococci to murine macrophages. The assay correlated well with direct 
microscopic quantification of adherence. As few as 3.8 x 104 bacteria per assay 
well or less than 1 bacterium per macrophage could be detected. This assay is 
both quantitative and selective, and is readily adaptable for multiple sample 
analysis. It provides a valuable alternative to visual detection of bacterial 
adherence.
Introduction
The group B streptococcus (GBS) is the single most common agent 
associated with bacteremia and meningitis during the neonatal period (75). 
Polymorphonuclear neutrophils are known to phagocytose and destroy these 
bacteria, but this requires opsonization with either specific antibody or
16
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complement (88). I have been examining the possibility that in individuals 
such as neonates, for whom serum opsonins may not yet be fully functional, 
macrophages serve to recognize and destroy potential pathogens in the 
absence of serum factors. As part of that study I required an in vitro binding 
assay for measuring the adherence of GBS to host defense cells.
My initial studies used the binding assay developed by Glass et al. (27), 
which involves the direct microscopic examination of stained cells.
Although a valuable assay, it suffers from several limitations. The procedure 
is labor-intensive, the data are subjectively derived, and the assay lacks good 
reproducibility. Other protocols for measuring bacterial attachment to 
eukaryotic cells have been developed, including ones using fluorescence- 
activated cell sorting (61), fluorescence microscopy (59), radiolabeled bacteria 
(104), or electronic particle counters (31), but none provides the composite 
attributes of repeatability, versatility, and low cost I sought.
Ofek et al. (59) reported on a ELISA-based system for determining the 
adherence of bacteria to enterocytes or oral epithelial cells. Subsequently 
Athamna and Ofek (7) applied this approach to quantify the adherence of 
Klebsiella pneumoniae to mouse peritoneal macrophages. Here I report on 
an adaptation of this technique for quantifying adherence of a gram-positive 
bacterium to phagocytic cells.
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M aterials and m ethods
Bacteria Type II group B streptococci, strain 18RS21 (44), kindly provided by 
Dr. Dennis Kasper, Harvard Medical School, Boston, MA, were grown in 
Todd-Hewitt broth (Difco Laboratories, Detroit, MI) at 37°C to mid-log phase 
under static conditions. The bacteria were harvested by centrifugation and 
were washed in Dulbecco's phosphate-buffered saline (DPBS). Stock 
suspensions of GBS were stored at -70°C in DPBS containing 8% dimethyl- 
sulfoxide (DMSO; Sigma Chemical Co., St. Louis, MO). Before use in each 
assay frozen aliquots were thawed, washed with DPBS, and adjusted to the 
appropriate density. The concentration of bacteria in the suspension was 
determined by direct counts in a Petroff-Hausser chamber (C. A. Hausser and 
Son, Philadelphia, PA).
Macrophages Peritoneal exudate macrophages (pMe) from 8-12-week-old 
female BALB/c mice (originally obtained from Charles River Laboratories, 
Wilmington, MA and subsequently bred at our institution) were elicited by 
intraperitoneal injections of 2 ml of Brewer thioglycollate (Difco Labora­
tories). After 3 days the pMe were harvested by lavage using 10 ml of cold 
Medium 199 with Earle's salts (M199; Gibco Laboratories, Grand Island, NY). 
The pMe were washed twice by centrifugation at 100 x g, using cold M199 and 
resuspended in M199 to a concentration of 106 cells/m l.
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Antibody Rabbit antiserum against the cell wall polysaccharide of type n  GBS 
was kindly provided by Dr. Dennis Kasper.
Cell lines The WISH (ATCC CCL 25, Rockville, MD) and L929 (ATCC CCL1) 
cell lines were used as controls for bacterial attachment. Both cell lines were 
maintained in log phase using Minimal Essential Medium (MEM) with 
Earle's salts containing 15% fetal bovine serum (Hydone Laboratories, Logan 
UT), 2 mM L-glutamine (Gibco), and 100 pM non-essential amino adds 
(Gibco) at 37°C with 5% CO2, 95% air. The cell lines were harvested using 
0.05% trypsin-EDTA (Gibco) and resuspended in M199 at a concentration of 
10  ^ cells/ml.
Immobilization of cells onto the microtitration plate Two-hundred micro­
liters of pMa or of control cell lines (106 cells/ml) were distributed to the wells 
of a 16-chamber glass slide (Lab-Tek, Nunc, Inc., Naperville, IL). The cells 
were sedimented to the bottom of the plate by centrifugation at 100 x g for 5 
min (Beckman model TJ-6; with micro-plate carrier for the TH-4 rotor), then 
allowed to attach for 3 h at 37°C. The cell monolayers were washed twice 
with DPBS to remove unattached cells.
Microscopic assay for measuring GBS binding to pMo I developed a modifi­
cation of the original procedure (27). Suspensions of GBS in 100 pi of DPBS, at 
concentrations of 109, 2 x 106, and 4 x 107 bacteria/ml, were added to the pMe
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and control cells in duplicate. After incubation at 37°C for 1 h the wells were 
washed 4 times with DPBS to remove nonadherent bacteria. The chambers 
were then removed and the slide air-dried, fixed in methanol, and stained 
with a modified W right's stain (Leukostat, Fisher Scientific, Pittsburgh, PA). 
Approximately 200 pMe were examined per well for bacterial adherence. 
Those with 2 or more (27) or 5 or more bacteria attached were scored as 
positive.
ELISA Suspensions of GBS in 100 pi of DPBS, at concentrations of 109,2  x 108, 
and 4 x 107 bacteria/m l were added to the macrophage and control cells in 
quadruplicate. After incubation at 37°C for 1 h the wells were washed four 
times with DPBS to remove nonadherent bacteria. The plates were air-dried 
and fixed with methanol for 10 min. Bacteria extracellularly attached to 
macrophages or control cells were quantified by ELISA.
The choice of a control for bacterial adherence is crucial. We attempted to 
use empty plastic wells or wells coated with protein blocking agents such as 
bovine serum albumin, gelatin, or hemoglobin (59) as negative controls. In 
all cases I found a high degree of bacterial adherence to the empty wells or 
protein-coated wells when compared with bacterial attachment to pMe. For 
this reason I chose to compare bacterial attachment to two types of easily 
obtainable, non-phagocytic cell lines with that of the macrophage. By using 
either the epithelial-like WISH cell line or the fibroblast-like L929 cell line as
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controls for non-specific attachment of GBS to the wells of the assay chamber, 
I obtained low background ELISA readings in these wells, compared with 
ELISA values for GBS adhering to pMo.
The procedure of Athamna and Ofek (7) was modified for use with our 
system. To each well, containing methanol-fixed cells, was added 200 pi of 20 
mM phosphate, 0.15 M NaCl (PBS), pH 7.2, containing 1% gelatin (Bio-Rad 
Laboratories, Richmond, CA), to block nonspecific binding of antibody, and 10 
pg/m l of goat immunoglobulin G (Organon Teknika Corp., Durham, NC), to 
block the Fc receptors on the macrophages. After incubation for 1 h at 37°C, 
the monolayers were washed three times with PBS containing 0.05% Tween- 
20 (Bio-Rad; PBS-Tween), followed by the addition of 100 pi/w ell of specific 
anti-GBS serum diluted 1:500 in PBS containing 1% gelatin and 0.1% Tween- 
20 for 1 h at 37°C. The plates were washed three times with PBS-Tween, 
followed by the addition of 100 pi per well of horseradish peroxidase-labeled, 
affinity-purified anti-rabbit immunoglobulin G (Organon Teknika), diluted 
1:5000 in PBS-Tween + gelatin for 1 h at 37°C. After three washes with 
PBS-Tween, 200 pi of the substrate 3 ,3 ', 5 ,5'-tetramethylbenzidine (TMB; 
Sigma) in acetate buffer was added to each well. Since TMB is poorly soluble 
in aqueous solution, it was first dissolved in DMSO to a final concentration of 
42 mM and 1 ml of this TMB-DMSO solution was added dropwise with gentle 
shaking to 100 ml of 0.1 M sodium acetate-citric add  buffer, pH 4.9. Just before 
use, 14.7 pi of 30% hydrogen peroxide was added to the acetate buffer contain-
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ing TMB for a final concentration of 1.3 mM H2O2. H ie blue color was 
allowed to develop for 15 min at room temperature and the enzyme reaction 
was stopped with the addition of 50 ill of 2.0 M H2SO4 to each well. The 
absorbance was read at 450 nm (A450) with an ELISA plate reader (Whittaker 
M.A. Bioproducts, Inc., Walkerville, MD). The following control systems 
were included: [1] blank wells (no bacteria or eukaryotic cells), [2] wells with 
macrophages only (no bacteria), and [3] wells with control cells (no bacteria). 
These controls were included to ensure that the eukaryotic cells did not cross- 
react with the first antibody and to detect any nonspecific binding of the 
antibodies.
Determination o f the number o f bacteria per monolayer A standard curve 
made for each test served to estimate the number of bacteria per monolayer. 
For this purpose GBS of known concentration in 100 |il of distilled water was 
placed in the wells of a microtitration plate and allowed to dry overnight in a 
desiccator, followed by fixation with methanol for 10 min. An ELISA was 
performed on the immobilized bacteria as described above. The ELISA 
values, at A450, were plotted as a function of the number of bacteria in each 
well. The curve obtained was used to calculate the number of bacteria 
attached to the pMo or cell line monolayer from the ELISA values obtained 
in the test experiment.
The standard curve was adjusted for loss of dried bacteria due to washing
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following the procedure of Athamna and Ofek (7). GBS were grown in tryptic 
soy broth (Difco) containing 1.5 pCi of 5-[1251]iodo-2'-deoxyuridine (NEN- 
Dupont, Boston, MA)/ml to mid-log phase at 37°C under static conditions. 
The radiolabeled bacteria were harvested by centrifugation and washed free of 
excess radioactivity with DPBS. The bacteria were adjusted as above to the 
desired concentration and the radioactivity associated with the cells was 
determined using a gamma counter (Gamma 5500, Beckman Instruments, 
Inc., Fullerton, CA). The radiolabeled bacteria contained 3800 cpm/107 
bacteria. The bacterial suspension was diluted in distilled water, dried, and 
fixed onto two sets of flat-bottomed EIA/RIA Strip-Plate-8 (Costar Corp., 
Cambridge, MA). One of the sets was washed 9 times with PBS-Tween to 
duplicate ELISA washes and the radioactivity of the individual wells of the 
two sets was determined.
Determination o f the number of pMe per well This determination was 
based on the selective staining of the pMe nuclei with methylene blue, 
followed by extraction of the stain (10). Known concentrations of pMa in 100 
pi of M199 were sedimented in the wells of a microtitration plate, air-dried, 
and fixed with methanol. These monolayers were stained with 100 pi of 1% 
methylene blue solution/well for 10 min, followed by washing with boric add 
buffer (0.1 M boric add, 0.1 M KC1, pH 8 .6). The stain was extracted by adding 
0.1 N HC1 and the recovered solution read at A^o nm in the ELISA plate
24
reader. The A«o values of the extracted stain were plotted as a function of the 
number of pMe in each well to obtain a standard curve. This curve was used 
to estimate the number of pMo in each experimental well after extracting and 
reading the methylene blue stain from each test monolayer.
A standard curve made for each test served to derive the number of pMe 
per monolayer. After determination of the number of bacteria in the experi­
mental assays was completed, the same monolayers were washed and stained 
to quantify the number of pMe, using the standard curve previously derived.
Results
Standard curves for adherence o f GBS and pMo In order to quantify bacterial 
adherence using the ELISA system, it was first necessary to construct standard 
curves to determine the number of bacteria and of macrophages in each 
system. Serially diluted suspensions of GBS, dried and fixed on microtitra­
tion plates, were reacted with the ELISA reagents. As shown in Fig. 1, a linear 
relationship between the number of immobilized bacteria (expressed logarith­
mically) and the ELISA values was obtained over the range of 6 x 104 to 6 x 10* 
bacteria/well. To determine whether significant numbers of bacteria were 
lost during washing, surface-labeled (1251) bacteria were dried and fixed to the 
bottom of microtitration plate wells. One series was washed nine times while 






















Fig. 1. Standard curve for the determination of numbers of bacteria per well. 
ELISA values (A450) as a function of increasing numbers of dried, 
immobilized streptococci
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determined for each sample. The data, depicted in Table I, indicate there was 
negligible loss of radioactivity, and hence of bacteria, due to washing over the 
concentration range of 2 x 103 to 2 x 108 bacteria added.
The number of adherent pMo was estimated by staining with methylene 
blue and quantifying the extracted dye. As shown in Fig. 2, the A*20 values of 
the extracted methylene blue were linear over the range of 105 to 106 
pM o/well. These standard curves were made in each experiment and used to 
determine the number of adherent bacteria per pMo, which was calculated by 
dividing the total number of adherent bacteria by the total number of 
pM o/well.
Adherence assays measured by ELISA The number of pMo or control cells 
added to each well of the assay plate was 2 x 10s. Approximately 1 x 105 pMo 
were immobilized per well, as determined from the pMe standard curve.
This number of cells formed a complete monolayer covering the surface area 
of the well. By visual inspection the WISH and L929 cells also completely 
covered the surface area of the well. Thus, any differences in ELISA values 
between wells containing immobilized pMe and those with control cells is a 
reflection of specific bacterial adherence to the pMe.
The adherence of GBS to pMo was dose-dependent over the concentration 
range of bacteria added, namely 4 x 106 to 1 x 108/  well. Adherence of less than
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TABLE 1
EFFECT OF WASHING ON THE ADHERENCE OF BACTERIA 
Use of 1251-labeled GBS







2x108 36403±353 356871477 98
4x107 69901116 6848165 98
8x106 1372115 135318 99
1.6x106 301 ±13 323112 107
3.2x105 106111 104119 98
6.4x104 5718 58113 102
1.3x104 4317 50116 116
2.6x103 4915 5413 110
2 Mean ± S.E. (n = 4)
0 1 2 
Bacteria/well
3
Fig. 2. Standard curve for the determination of numbers of macrophages per 
well. Values of extracted methylene blue stain (A*2o) as a function of number 
of sedimented and dried peritoneal macrophages.
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one bacterium per cell was detected by the ELISA technique (Table 2). To 
confirm that ELISA readings corresponded to bacterial adherence to pMe, the 
bottoms of the wells were cut off and mounted onto a glass microscope slide, 
and the number of adherent bacteria per pMo or control cell was counted 
microscopically. There was a good correlation between the ELISA readings for 
adherence and the values obtained by direct microscopic counts.
Comparable studies performed with non-phagocytic cell lines revealed 
significantly lower values for microbial adherence. Even at the highest 
dosage tested (1 x 108 bacteria added), the binding ratios were at least ten-fold 
lower than those for pMo.
Visual assay for detecting microbial attachment Standard adherence assays 
were performed by a modification of the technique developed by Glass et al. 
(27). For each assay system two values were determined: the number of pMe 
with 2  2 bacteria attached and the number of pMe with £ 5 bacteria attached. 
The former is the value used in the original description of this protocol, 
while the latter is a more rigorous criterion used in our laboratory.
The results of these assays are summarized in Table 3. As expected, there 
was a positive correlation between the number of bacteria added and the 
percentage of pMo exhibiting adherence. This was true regardless of which 
binding criterion was used. At the higher level of GBS added (1 x 108) 
virtually all the pMe bound at least 2 bacteria; however, only one-third of
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TABLE 2
ATTACHMENT OF GROUP B STREPTOCOCCI TO MACROPHAGES AND 
CONTROL CELL LINES
Number of bacteria per well is based on ELISA values.
Cells GBS added/w ell Ratio of added 
GBS/Mo*
Mean no. (± S. E.) of 
GBS bound per Meb
pMo 1x108 1000:1 8.5 ±1.7
2x107 200:1 1.5 ±0.4
4x108 40:1 0.38± 0.03
L929 1x108 1000:1 0.67± 0.10
2x107 200:1 0.27± 0.06
4x106 40:1 0.13± 0.04
WISH 1x108 1000:1 0.53± 0.06
2x107 200:1 0.22± 0.04
4x106 40:1 0.15 ±0.01
a-105 M o/well 
b n = 12
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TABLE 3
ATTACHMENT OF GROUP B STREPTOCOCCI TO MACROPHAGES AND 
CONTROL CELL LINES
Numbers are based on visual assessment by direct microscopic counting
Cells GBS added Percentage with 
2  2 bacteria/cella £ 5 bacteria/cella
pMo 1x108 96 ±1.2 33 ±3.5
2x107 82 ±1.7 9.7± 2.1
4x106 10 ± 2.0 1.9± 0.8
L929 1x108 7.6± 1.1 2.7± 0.42
2x107 1.9± 0.02 0.13 ±0.02
4x106 0.40 ±0.04 0.05± 0.02
WISH 1x108 6.0 ±0.57 2.3± 0.4
2x107 1.6 ±0.26 0.09 ±0.02
4x106 0.34 ±0.05 0.05 ±0.03
a Mean ± S. E. (n = 6)
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them scored positive when the criterion was 2  5 bacteria bound per cell. 
Comparable studies with non-phagocytic cell lines revealed adherence values 
10 times lower for each concentration of GBS tested, confirming that the 
adherence was not a general eukaryotic cell function.
As shown in Fig. 3, there was good correlation between the ELISA readings 
for adherence and the values obtained by direct microscopic counts.
Discussion
Phagocytosis of microorganisms is an important host defense among 
members of the animal kingdom. In order for phagocytosis to be initiated 
there must be contact between the engulfing cell and the potential pathogen. 
Assuming that these are not chance encounters there must be some form of 
recognition between these two participants. In the case of non-opsonin- 
mediated phagocytosis the ability to phagocytose microorganisms must be due 
to inherent properties of the host cell, most likely structures located on the 
plasma membrane.
As part of our studies to identify the receptor on the mouse pMo respon­
sible for recognition of GBS I sought a relatively inexpensive binding assay 
that could be readily performed and would give reproducible results. An 
enzyme-linked assay has the potential to provide objective data and to allow 




Fig. 3. Comparison of bacterial binding obtained from the direct visual assay 
and from ELISA. Plot with open squares relates results from visual assay (Me 
binding 2:2  bacteria) with ELISA data (number of bacteria bound per Me).
Plot with closed squares depicts a comparable relationship between visual 
assay (Me binding 2  5 bacteria) and ELISA data.
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developed an ELISA-based adherence assay using K. pneumoniae and mouse 
pMe. My studies indicate that this assay can be modified to detect binding of 
GBS to pMe.
In this system bacteria are allowed to adhere to monolayers of pMa and 
their presence is both detected and quantified by an ELISA, using specific 
antibody to the bacteria as the primary antibody. To calculate binding ratios it 
was first necessary to verify the numbers of each cell type in our assay 
chambers. Standard curves plotting the numbers of bacteria per well vs. 
absorbance at 450 run (to detect the product formed by horseradish peroxidase 
in the antibody-enzyme conjugate; Fig. 1) and the number of pMe per well vs. 
absorbance at 620 nm (to detect the methylene blue eluted from stained pMo; 
Fig. 2) each yielded sigmoidal dose-response curves with linear mid-sections.
Using this approach determined the binding ratios for GBS and murine 
pMo. As shown in Table 2, the data obtained are highly replicable. At high 
ratios of added bacteria to pMe (1000:1) our system detected 7-10 bacteria per 
pMe, whereas at a lower ratio (200:1) there were 1-2 bacteria detected per pMe. 
Under comparable conditions the control eukaryotic cells consistently 
exhibited bacterial binding ratios of <1 per cell.
Data presented in Table 3 provide information obtained from bacterial 
binding studies using direct microscopic counting. As with the ELISA-based 
system, results from the direct counting assays also yielded a positive dose- 
response effect. Similarly, the control cells gave consistently low binding
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values.
Although the ELISA-based system for quantifying bacterial binding to 
eukaryotic cells provides some obvious advantages over direct visual assay, 
each system is, in fact, assessing a somewhat different aspect of adherence. 
Using ELISA we can obtain information on a population of Mo, but we 
cannot determine the distribution of the bound and detected bacteria over 
this population. That is, we can calculate an average binding ratio, e.g., 8.5 
bacteria per pMe, but we cannot ascertain the binding properties of individual 
Me; for this the visual assay system remains the definitive procedure.
Nonetheless the use of an ELISA-based approach to measure bacterial 
adherence provides a valuable tool for screening various assay conditions or 
treatments to determine their effect on binding, since many variables can be 
simultaneously tested. The ability of this system to detect as few as 3.8 x 104 
GBS compares favorably with the data of Athamna and Ofek (7) in which they 
detected 5 x 104 K. pneumoniae. These studies indicate that an ELISA-based 
system has broad application in studies on microbial phagocytosis.
CHAPTER 2
CHARACTERIZATION OF THE MURINE MACROPHAGE RECEPTOR FOR
GROUP B STREPTOCOCCI
Abstract
I have examined the role of the galactose receptor for the non-opsonin 
mediated adherence of group B streptococci (GBS) to murine peritoneal 
macrophages (Me). The effects of sugars and neoglycoconjugate proteins of 
bovine serum albumin (BSA) that are known to bind to the lectin-like 
receptor on the inhibition of GBS binding to peritoneal macrophages was 
investigated. These studies required stringent conditions, both a visual assay 
and enzyme-linked immunosorbent assay (ELISA), for quantifying binding 
and the subsequent inhibition of binding. Using these assay conditions I 
observed no inhibition of binding by monosaccharides, including methyl-P- 
galactoside, at concentrations as high as 200 mM or the neoglycoconjugate 
protein, galactose-BSA, at 2 m g/m l (-29 |iM galactose). To increase the 
exposure of capsular galactose, terminal sialic add was removed by treating 
GBS with neuraminidase from V. cholerae. Dose-dependent binding of
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neuraminidase-treated and untreated GBS types lb, II and HI was similiar. In 
addition, the binding profile was similar for wild-type and isogenic strains of 
type m  GBS having no capsule or no capsular sialic add. Galactose or 
galactose-BSA failed to inhibit binding of any of these strains. These results 
suggest that there is no involvement of the galactose lectin-like receptor on 
murine peritoneal macrophages with the binding of GBS in the absence of 
serum opsonins.
Introduction
Group B streptococd (GBS) are a major cause of neonatal meningitis and 
septicemia in the United States (80) and in post-par turn infections. 
Increasingly they are being recognized as an important pathogen in non­
pregnant adult humans as well (81). Phagocytosis of these organisms 
followed by intracellular killing is considered to be the major host defense in 
mammals and serum opsonins, e.g., anti-capsule antibody and complement, 
have been shown to play a major role in effecting endocytosis (13).
GBS also bind directly to mammalian macrophages in the absence of 
serum opsonins (see Chapter 1; ref. 25). Non-opsonin-mediated phagocytosis 
can be achieved by membrane-assodated lectins on the macrophage reacting 
with complementary sugar residues on the microbial surface (106, 82).
These baderia are typically encapsulated and the structures of these
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polysaccharide capsules form the basis of serotype designations (39,38,41.40). 
Currently four serotypes, la, lb, n, and m, are recognized; their basic structure 
is shown in Fig. 1 (p. 9, Chap. 1; ref. 44). The backbone in each case is 
composed of a repeating unit of 2 to 5 monosaccharides, while the side chain 
P-D-galactose is either exposed or penultimate to a terminal sialic add.
My hypothesis, then, was that macrophage-derived lectins mediate the 
recognition and binding of GBS. The data reported here do not support this 
hypothesis.
Materials and Methods
Chemicals All reagents were obtained from Sigma Chemical Co., St. Louis, 
MO unless otherwise noted.
Bacteria Prototypic strains of GBS, representing two serotypes, originally 
obtained from the late Dr. Rebecca Lancefield, Rockefeller University, were 
provided by Dr. Dennis Kasper, Harvard Medical School. These strains are 
designated H36B (type lb), 18RS21 (type II) (44). Two type m  GBS strains M732 
and COH31, originally clinical isolates from infants with meningitis (44), were 
also provided by D. Kasper. All strains were obtained as frozen suspensions 
of pure cultures, which were stored at -70°C. Each strain was streaked onto a 
5% blood agar plate and incubated overnight at 37°C. A colony from each 
strain was used to inoculate 10 ml of Todd-Hewitt broth (Difco Laboratories,
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Detroit MI) and this was incubated overnight to stationary phase. A 5-ml 
volume of each strain was used to inoculate one liter of Todd-Hewitt broth 
and this was incubated at 37°C to log phase under static conditions. The 
bacteria were harvested by centrifugation at 10,000 xg for 10 min and were 
washed three times in Dulbecco's phosphate-buffered saline (DPBS). Stock 
suspensions of GBS were adjusted to a density of 1010/m l as determined by 
direct counts in a Petroff-Hausser chamber (C. Hausser and Son, Philadelphia, 
PA) and were stored at -70°C in DPBS containing 8% dimethylsulfoxide 
(DMSO). Before use in each assay, frozen aliquots from the original batch 
culture of each strain were thawed and washed with DPBS to insure 
continuity between experimental studies performed on different days.
Neuraminidase treatment o f GBS Desialylation of GBS strains H36B, 18RS21, 
M732 and COH31 was done by adding 0.15 units of neuraminidase from 
Vibrio cholerae, (Sigma, Type n, specific activity: 10 units/m g protein using 
NAN-lactose) to 3 ml of bacterial suspension at 1010/m l in 0.05 M sodium 
acetate buffer, pH 5.5, containing 154 mM NaCl and 9 mM CaCl2 (27). After 1 
h at 37°C with constant end-over-end rotation, the bacteria were washed three 
times with DPBS and stored in 8% DMSO as described above. Nondesial- 
ylated bacteria were treated likewise but without the addition of neuramini­
dase.
Isogenic strains o f type III GBS COH31 Capsular mutants of GBS type m
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strain COH31 obtained from D. Kasper (Harvard) were derived by Tn916 
transposon mutagenesis. The mutant strain designated COH31-15 does not 
react with type m  GBS antiserum from rabbits and has no visible extracellular 
capsule material when visualized by electron microscopy (45). Another 
mutant strain designated COH31-21 is lacking terminal sialic add  on the side 
chain, leaving (to-galactose as the terminal sugar.
Interaction o f GBS with Ricinus communis agglutinin The availability of 
galactose residues on the surface of GBS was verified by the aggregation of a 
1% suspension of each strain by the galactose-specific lectin from Ricinus 
communis (castor bean) at a concentration of 0.2 pg/m l. D(+)-Galactose, d (+ )- 
glucose and methyl f)D-galactopyranoside were tested at concentrations of 10 
m g/m l, 1.0 m g/m l and 0.1 m g/m l for their ability to inhibit the aggregated 
GBS.
Detection o f fi-glucan receptor on Mo The P-glucan receptor found on Me 
was used as a control system for the inhibition studies. Saccharomyces 
cerevisiae and a preparation of its cell wall as particulate zymosan have been 
shown to bind to Me in the absence of serum opsonins (96). Zymosan 
partides consist almost exdusively of two types of carbohydrate polymers: p- 
glucans, which are the major constituents, and a-m annans (22). Macrophage 
binding of S. cerevisiae zymosan is inhibited most effectively by the soluble P* 
glucans purified from yeast extract or yeast glucan partides with 1 3 - and/or
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1,6-glycosidic linkages (37), whereas P-glucan from barley with 1,4-linkages are 
not (17,18). Homopolysaccharides containing epimers of glucose, such as 
galactans and yeast a-mannans are not inhibitory even though they contain 
1,3- and/or 1,6-linkages.
p-Glucan from 5. cerevisiae inhibits binding through the P-glucan 
receptor (19). I have exploited this mechanism for macrophage binding to a 
surface structure of yeast as a positive control in our inhibition studies. A 
suspension of zymosan A from Saccharomyces cerevisiae, measuring 3-4 pm 
in diameter, was prepared by sonication using a pulsed cycle for 30 seconds, at 
output setting 4,50% duty cycle (Heat Systems Ultrasonics, Inc. Plainview, 
NY) in DPBS. Soluble a-mannan and P-glucan from S. cerevisiae and p- 
glucan from barley were tested for their ability to inhibit binding of zymosan 
to Mo. The lowest concentration of each capable of yielding 50% inhibition of 
zymosan attachment to Mo at particle concentrations of lOVml and 108/ml 
was determined by the visual assay.
Macrophages Peritoneal exudate macrophages (Mo) from 8 to 12 week-old 
female BALB/c mice were elicited by intraperitoneal injections of 2 ml of 
Brewer thioglycollate (Difco Laboratories). After 3 days the Mo were har­
vested by lavage using 10 ml of RPMI medium (Gibco Laboratories, Grand 
Island, NY). The Mo were washed twice by centrifugation at 100 xg for 10 
min, using cold RPMI and resuspended in RPMI to a concentration of 106
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cells per ml.
Antisera to GBS Group-specific and type-specific antisera to GBS, prepared in 
rabbits, was kindly provided by Dennis Kasper, Harvard Medical School.
Binding Assays Adherence of GBS to Me was determined either by direct 
microscopic observation or by an ELISA-based system, using previously 
described methodology (see Chapter 1).
Inhibition studies Macrophage monolayers were pre-incubated with 
monosaccharides in DPBS for 30 min and then for 1 h in the presence of 
bacteria. The following monosaccharides were used at concentrations of 2,20 
and 200mM: D(+)-galactose, methyl a-D-galactoside, methyl ^-D-galactoside, 
D(+)-glucose, methyl a-D-glucoside, methyl ^-D-glucoside, D(+)-mannose, 
methyl a-D-mannoside, methyl a-L-fucose, N-acetyl-D-glucosamine 
(GluNAc) and iV-acetyl-D-galactosamine (GalNAc). Neoglycoconjugates 
prepared by E Y Laboratories, San Mateo, CA, from bovine serum albumin 
(BSA), containing 30 to 40 mole saccharide per mole BSA, were tested for 
their ability to inhibit binding of GBS to macrophages. Glucosylated-, 
galactosylated- and mannosylated-BSA were incubated with the Me 
monolayers as described for the monosaccharide solutions at concentrations 
of 20,200 and 2000 pg/m l. The concentrations of the monosaccharide were 
equivalent to approximately 11,110 and 1100 pM, respectively.
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Unconjugated BSA, Fraction V, was included as a negative control at the 
same protein concentrations.
Results
Effect o f sugars as inhibitors o f GBS adherence to macrophages A compar­
ison was made between galactose and other monosaccharides as well as BSA- 
glycoconjugates for the inhibition of type II and m  GBS adherence to perito­
neal macrophages. Using the visual assay I found there was no significant 
inhibition of the binding of either serotype by galactose or any of the other 
sugars at concentrations < 200mM (Table 1) or the neoglycoconjugates at 
concentrations <2mg/ml (Table 2). The specific binding of zymosan particles 
from S. cerevisiae to the p-glucan receptor on Mo was included as a positive 
control to verify that the visual assay can quantify receptor inhibition (Table 
3). The data in Table 1 suggest that the mechanism for type n  and m  
adherence was not due to the galactose receptor on the macrophage, since 
there was no difference in binding by serotype or inhibition of binding 
specifically by galactose.
Effect of desialylation o f capsular GBS polysaccharide The binding of GBS to 
Mo may be due to more than one type of mechanism including the galactose 
receptor. However, the inability of galactose to inhibit binding could be due 
to the masking effect of terminal sialic acid. GBS types lb, II and m  were
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TABLE 1
EFFECT OF MONOSACCHARIDES AS INHIBITORS OF GBS ADHERENCE 
TOMo
Strain of GBS
Inhib ito r 18RS21 M732 COH31
PBS 100±llb 10018 100112
D(+)glucose 6 2 1 9c 55113 64112
Methyl-a-glucose 69113 45112 6016
Methyl-|)-glucose 5917 58110 7618
D(+)galactose 69112 5818 68115
Methyl-a-galactose 6418 55114 76112
Methyl-P-galactose 64110 55111 6816
L(-)fucose 6416 58111 7619
D(+)mannose 76114 6319 8010
Methyl-a-mannose 71112 84114 90112
N-acetylglucosamine 6918 7717 96110
N-acetylgalactosamine 6618 6816 96110
a Inhibitors were used at concentrations of 200 mM 
b Percentage binding ± S.E. (N=8)
c Analysis of variance for all systems (excluding PBS controls) indicated no 
statistically significant difference in the effects of the test sugars on 
bacterial adherence (F = 2.113; p = 0.0785)
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TABLE 2.
EFFECT OF BSA-GLYCOCONJUGATES AS INHIBITORS OF GBS 
ADHERENCE TO Me
Inhibitors* 18RS21
Strains of GBS 
M732 COH31
PBS 100 ±8b 100110 100115
Glucose-BSA 112±18c 10018 9619
Galactose-BSA 115 ±20 100110 11516
Mannose-BSA 112 ±9 94112 104112
Glucose/galactose-BSA 112112 115113 133115
Glucose/ mannose-BS A 106111 106115 136121
Galactose-mannose-BSA 11519 9417 133116
* Inhibitors were used at concentrations of 2 mg/ml. 
b Percentage binding ± S.D. (N=8)
c Analysis of variance for all systems (excluding PBS controls) indicated no 
statistically significant difference in the effects of the test glycoconjugates 
on bacterial adherence (F = 1.18; p = 0.38)
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TABLE 3
INHIBITION OF BINDING OF SACCHAROMYCES CEREVISIAE ZYMOSAN 
PARTICLES TO Me
Number of zymosan partides added 
Inhibitor 10®/m l 108/ml
P-glucan (yeast) 0.5 mg/ml® 0.1 m g/ml
P-glucan (barley) > 10 mg/ml > 10 mg/ml
a-mannan (yeast) > 10 mg/ml > 10/mg/ml
a lowest concentration to yield 50% inhibition of binding. Representative 
data from visual binding assay.
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treated with neuraminidase from V. cholerae to remove this sialic add. I 
employed the lectin from Ricinus communis (castor bean) with a known 
spedfidty for fi-D-galactose to determine if this residue was exposed following 
neuraminidase treatment. Table 4 represents results by slide agglutination for 
treated and untreated GBS. Agglutination of GBS by the castor bean lectin 
was specifically inhibited by D(+)galactose and methyl-^-galactoside, whereas 
D(+)glucose had no effed. Although desialylation by neuraminidase was 
shown to expose galactose residues, dose-dependent binding of neuramini­
dase-treated and untreated GBS type lb, II and m  to Me as determined by 
ELISA is similar (Figure 1).
Comparison o f type III isogenic strains for adherence to macrophages A  
further study comparing macrophage adherence of wild-type COH31 to 
isogenic strains of GBS type in, derived by Tn916 transposon mutagenesis and 
having no capsular sialic add (COH31-21) or no capsule expressed (COH31-15) 
was performed by the visual assay. Table 5 represents data from three 
experiments in which the binding of all isogenic strains was similiar, about 
35% and 12% for bacterial concentrations of 109/m l  and 108/ml, respectively. 
As in previous studies 200 mM galactose was shown to have no inhibitory 
effect on the binding of any of the GBS isogenic strains to Mo, suggesting no 
involvement of the galactose lectin receptor.
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TABLE 4
EFFECT OF MONOSACCHARIDES ON THE AGGLUTINATION OF 
NEURAMINIDASE-TREATED AND UNTREATED GBS BY RICINUS 
COMMUNIS AGGLUTININ
Inhibitor®
GBS strain Treatment^ PBS D(+)-gal Me^-gal D(+)-glc
18RS21 - + <10c <10 >10
+ + + <1 <0.1 >10
M732 - - NT NT NT
+ + + <1 <0.1 >10
COH31 - - NT NT NT
+ + + <1 <0.1 >10
COH31-15 - - NT NT NT
COH31-21 - + + <1 <0.1 >10
* inhibitors: PBS -  control; D(+)-gal: D(+)-gaIactose; Mep-gal: methyl-{J- 
galactoside; D(+)-glc D(+)-glucose 
b +, neuraminidase-treated; untreated
c concentration that effected 50% inhibition of agglutination; NT, not tested
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Fig. 1. Effect of neuraminidase treatment on adherence of four GBS strains to 
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* -  none added; +, 200 mM D(+)-galactose added 
b percent binding ± S.D. (N = 6)
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Discussion
Evidence from in vitro studies indicate that phagocytosis of bacteria occurs 
in opsonin-free media (20, 33, 43, 53, 69, 70, 71), while findings from in vivo 
studies show clearance of bacteria from the serum opsonin-deficient lungs by 
alveolar macrophages (28, 51) or from the blood by the reticuloendothelial 
system of animals depleted of complement (11). The molecular basis for non- 
opsonic recognition between bacteria and phagocytes is largely unknown.
Several investigators have postulated that the net surface charge or the 
hydrophobidty of particles or bacteria determines whether they can be bound 
by phagocytes (92,102), but no direct evidence for these assumptions has been 
obtained. It is still possible that nonspecific or ill-defined surface properties 
may account for the recognition by phagocytes of some particles (e.g., poly­
styrene beads). However, as pointed out by Griffin (33), recognition of most 
physiologically relevant particles must involve more specific mechanisms.
During the last decade, considerable evidence has accumulated showing 
that specific recognition by phagocytes may be accomplished by the interaction 
of carbohydrate-binding proteins, e.g., lectins, in the cytoplasmic membrane of 
this defense cell with complementary sugars on the target cell (82,83). This 
type of recognition, which also leads to phagocytosis, has been termed lectino- 
phagocytosis (60). Macrophages have several cell-associated lectins that have 
been implicated in microbial recognition (30). A mannose-spedfic receptor
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on human macrophages has been shown to recognize mannose-bearing 
pathogens and to mediate their internalization (24). The mannose/ fucosyl 
receptor (MFR) recognizes Leishmania promastigotes and synthesis of reac­
tive oxygen metabolites is triggered by adherence to this receptor (46). Human 
monocytes bear p-glucan receptors that react with zymosan particles (19), thus 
providing the cells with the ability to detect microorganisms bearing this 
glycan in the absence of serum factors. The clearance of Klebsiella pneumo­
niae from the lung may be due to a mannosyl/N-acetyl-D-glucosaminyl 
receptor found on alveolar macrophages (7).
Rat Kupffer cells in vitro strongly bind neuraminidase-treated rat ery­
throcytes but not untreated erythrocytes (49). Preincubation of the macro­
phages with D-galactose and related sugars inhibits cell adherence and 
suggests that the galactose-specific lectin receptor recognizes senescent 
erythrocytes (79).
In this study we attempted to show involvement of the galactose receptor 
for the non-opsonin-mediated adherence of GBS to peritoneal macrophages. 
My results, however, do not support this hypothesis. First, none of the 
monosaccharides or BSA-glycoconjugates acted as a specific inhibitor of type II 
and m  GBS adherence to macrophages (Table 1,2). Second, neuraminidase- 
treated GBS, which were shown to have galactose exposed on their surface by 
agglutination with a galactose-specific lectin (Table 3), bound to peritoneal 
macrophages, but the binding could not be reduced by pre-exposure of the
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macrophages to galactose (Table 4), again suggesting no involvement of the 
galactose receptor on the macrophage. Third, isogenic strains of type HI GBS 
having no capsule or no sialic add expressed, leaving galactose residues 
exposed, exhibited the same degree of attachment as wild-type type III to 
macrophages (Table 5).
Attachment with subsequent phagocytosis of microbial elements such as 
zymosan mediated by the P-glucan-type lectin on the surface on the surface of 
macrophages has been described by Czop et al. (19). This binding is inhibited 
most effectively by the soluble P-glucan from S. cerevisiae with 1,3 or 1,6 
glycosidic linkages (37); P-glucan from barley with 1,4 linkages is not inhibi­
tory (17,18). Homopolymers containing epimers of glucose, such as galactans 
or yeast a-mannans are also non-inhibitory, even though they contain 1,3 or 
1,6 linkages. My results (Table 3) confirmed the presence of the P-glucan-type 
receptor on the Me. Additionally, this system served as a positive control for 
our inhibition studies.
Inhibition of blood clearance of neuraminidase-treated type I GBS, which 
express galactosyl residues on their surfaces, was shown to be strongly inhibi­
ted by galactosyl- but not by mannosyl- or fucosyl-BSA (65). In the same study 
the blood clearance of type n  GBS could be inhibited by neither galactosyl- or 
mannosyl-BSA alone, whereas the presence of both neoglycoconjugates in the 
injected suspension significantly inhibited the blood clearance of streptococci. 
No such synergism was obtained in my experiments with type II and HI GBS
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adherence to murine peritoneal macrophages. These results suggest that 
lectins expressed on the surface of phagocytic cells in the liver are not present 
on peritoneal macrophages. However, in the same study (65) the adherence 
of type n  GBS to Mo was inhibited by galactosy-, mannosyl- and glucosyl-BSA. 
As with blood clearance, the combination of galactosyl- and gluoosyl- or 
mannosyl-BSA significantly increase the inhibition of attachment.
Differences in the results of my studies and those of Perry et of.(65) can not 
fully be explained by the difference in the type of phagocytic cell used (perito­
neal macrophage vs. Kupffer) or the strain of mouse used (BALB/c vs. ICR) or 
the different strains of GBS. In my studies, the stringency of my conditions 
for detecting inhibition of adherence of GBS to Mo suggests another receptor 
or combination of multiple receptors for microorganisms that represents an 
efficient and potent defense mechanism for non-opsonin-mediated adher­
ence. Possible candidates for these receptors may the macrophage integrins. 
The p2 integrins CR3 and LFA-1 have been implicated in the phagocytic 
uptake of Staphylococcus epidermidis (96). Preliminary studies in our labora­
tory suggest that these leukocyte integrins are also the receptors involved in 
attachment of GBS.
CHAPTER 3
CHARACTERIZATION OF THE INTERACTION BETWEEN GROUP B 
STREPTOCOCCI AND THIOGLYCOLLATE-EUOTED PERITONEAL
MACROPHAGES
Abstract
Macrophages have been shown by several investigators to recognize and 
bind group B streptococci (GBS) in the absence of serum opsonins. The 
mechanism for this binding has not been elucidated. I have shown this 
mechanism to involve a protein receptor on the macrophage since the 
binding of GBS is sensitive to trypsin treatment. Other characteristics of this 
binding, such as temperature dependence and a requirement for divalent 
cations suggest that the receptor involved is not the lectin-like galactose 
receptor. Treatment of the macrophages with 2-deoxy-D-glucose, at concen­
trations of 0.5 mM and 50mM, decreased GBS binding by 33% and 90%, 
respectively. Two-deoxy-D-glucose has been shown to inhibit Fc and 
complement receptor-mediated binding by mouse peritoneal macrophages. 
The function of receptors for the third component of complement (C3) to 
bind ligand-coated particles may be altered dramatically when macrophages
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attach to surfaces coated with fibronectin (FN) or after macrophages are 
exposed to phorbol esters. Here I show that when phorbol dibutyrate (PDB) is 
present during the incubation of GBS and macrophages monolayer, binding 
doubles. In addition, when macrophages are allowed to attach to an FN- 
coated surface, in the presence or absence of PDB, binding of GBS also 
increases two-fold. Neutrophil elastase has been shownto cleave the C3b 
receptor, CR1, but not the C3bi receptor, CR3. When I treated the macrophage 
monolayers with neutrophil elastase, the binding of GBS was unchanged. 
These results suggest that the binding of GBS by peritoneal macrophages, in 
the absence of serum components, may be mediated by CR3.
Introduction
Phagocytic cells in higher animals are capable of discriminating between 
foreign material and self components. They are also able to distinguish 
between self and alterations to self, as in effete or damaged cellular compo­
nents or aberrant self constituents, such as tumor cells (47). The recognition 
abilities that underlie this discriminating capacity must have evolved with 
the emergence of primitive species. Some form of self recognition mechan­
ism is likely to have formed the basis of the abilities of colonial marine 
species such as Porifera to exclude unrelated organisms from inclusion in 
their colonies (105). In addition the cells lining the cavity of Porifera are
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capable of capturing microorganisms present in the water drawn into the 
cavity. Phagocytosis also plays a role in the metamorphosis of insects in 
removing dead cells and disintegrated tissue (26). The role of invertebrate 
amebocytes in recognizing and engulfing foreign material is likely to be a 
development of these earlier, more primitive recognition mechanisms and 
begins to involve cooperation with soluble factors present in the hemo- 
lymph, acting as opsonins (67).
In vertebrates further specialization has occurred, involving cooperation 
between phagocytes and components of the immune system including anti­
bodies, complement and lymphoid cells. The more primitive forms of 
phagocyte recognition appear, however, to have been retained and the cells 
appear to be able to recognize and bind foreign particulate material without 
the use of their more recently evolved receptors for the Fc component of the 
immunoglobulin molecule or the C3b component of the complement system 
(94).
I have observed nonopsonin-mediated binding of group B streptococci 
to murine peritoneal macrophages. Attempts to demonstrate adherence of 
exposed galactose of the bacterial capsule to the known macrophage mem­
brane galactose receptor have been unsuccessful (see Chapter 2). In this study 
I have compared characteristics of the adherence of type III GBS to murine 
peritoneal macrophages with known characteristics of macrophage bacterial 
receptors in an attempt to identify whether a previously characterized mem-
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brane receptor is responsible for this initial recognition.
Material and Methods
Chemicals All chemicals were obtained from Sigma Chemical Co. (St. Louis, 
MO) unless otherwise noted.
Bacteria A culture of type m  Group B streptococci, designated as strain 
COH31, was kindly provided by Dennis Kasper, Channing Laboratory 
(Harvard Medical School). This strain was originally isolated from an infant 
with meningitis (44). Capsular mutants of GBS type m  strain COH31 were 
obtained from D. Kasper (Harvard) and are previously described (see Chapter 
2). All strains were maintained, and prepared for the assay as previously 
described (see Chapter 2).
Macrophages Macrophages were prepared as previously described (see 
Chapter 2).
Assay o f GBS adherence Monolayers of macrophages (prepared as previous­
ly described in Chapter 2) were layered with 0.2 ml of GBS at densities of 
10io/ml and lOVml in DPBS and incubated at 37°C in the CO2 chamber for 1 
h. Bacteria were added and adherence quantified as previously described (see 
Chapter 1).
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Treatment o f macrophage monolayers with trypsin The procedure for trypsin 
treatment of macrophage monolayers was a modification of that devised by 
Czop et al. (16). Macrophages were layered with 0.25 ml analytical grade, 
bovine pancreatic trypsin (Boehringer Mannheim, Indianapolis, IN) having a 
specific activity, determined by the manufacturer, of 40 U /m g lyophilized 
material (25°C; benzoyl-L-arginine ethyl ester as substrate). The trypsin was 
diluted in RPMI containing an additional 5 mM MgCh, over the range of 4.0 
Hg/ml to 4.0 mg/ml, and the treated macrophages were incubated at 37°C for 
30 min in the CO2 chamber, and rinsed twice with RPMI. Each monolayer 
was then layered with 0.25 ml aprotinin (Trasylol ™, 200 U /m g lyophilizate 
trypsin inhibitor units, Boehringer Mannheim) at varying molar concen­
trations selected to be the equivalent of the previous trypsin concentration, 
incubated for 15 min at 37°C, rinsed four times with RPMI, and overlaid with 
wild-type COH31 and the two isogenic strains of GBS for detection of adher­
ence. Treatment of macrophage monolayers with aprotinin alone, at any of 
the concentrations tested, followed by washing did not inhibit adherence.
Treatment o f macrophage monolayers with neutrophil elastase Lyophilized 
human neutrophil elastase (Sigma) with a specific activity of 110 U /m g 
protein (determined and defined by the manufacturer as: one unit will release 
one nanomole of p-nitrophenol per second from N-t-BOC-L-alanine p- 
nitrophenyl ester at pH 6.5 at 37°C) was dissolved in sterile distilled water at
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1 m g/ml and stored in small aliquots at -70°C. Macrophage monolayers were 
treated with 0.25 ml of neutrophil elastase at final concentrations of 30,10 and 
3 ng/m l in DPBS for 1 h at 37°C, using a modification of the method of Tosi 
et al. (100). The elastase was removed by washing the chambers individually 
four times with DPBS followed by the addition of GBS for assay of adherence. 
In addition, we examined the effect of elastase treatment on macrophage 
monolayers morphologically at 1000 X magnification.
Treatment of macrophage monolayers with 2-deoxy-D-glucose I used a 
modification of the method of Sung and Silverstein (97) to examine the effect 
of 2-deoxy-D-glucose treatment of macrophages on their ability to bind GBS. 
Briefly, macrophage monolayers were incubated with 500, 50,5.0 and 0.5 mM 
2-deoxy-D-glucose for 2 h at 37°C, followed by the addition of GBS to the 
monolayers for 1 h at 37°C, without removal of 2-deoxy-D-glucose, for assay of 
adherence. The morphological effect of 2-deoxy-D-glucose on macrophages 
without the addition of GBS was examined at 1000 X magnification.
Role o f temperature and divalent cations on the adherence o f GBS to macro­
phages Macrophage monolayers were incubated with GBS strain COH31 as 
described in the adherence assay at 37°C and at the additional temperatures of 
20°C and 4°C to determine the effect of temperature on GBS adherence to Mo.
The effect of 0.5 mM MgCfe and CaCh on this adherence was also tested 
using a modification of the method of Wright and Jong (116). Thioglycollate-
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elicited peritoneal exudate cells were washed with Ca2+ and Mg2+- free DPBS, 
then incubated for 3 h in the chamber-slide to prepare macrophage mono­
layers absent of divalent cations. GBS strain COH31 was added to the macro­
phages as described for the adherence assay in DPBS containing both Ca2+ and 
Mg2+, DPBS containing either Ca2+ or Mg2+ and DPBS without divalent 
cations. Macrophage monolayers were exposed to these same conditions 
without GBS to observe morphological changes in macrophage adherence to 
the chamber-slide during the incubation period with bacteria.
Treatment o f macrophages with phorbol ester and/or ligation o f the macro­
phage fibronectin receptor on the adherence o f GBS by macrophage mono­
layers Preparations of macrophage monolayers was performed as described 
previously using eight-chamber tissue culture slides (Lab-Tek) having a 
plastic surface which enhances protein coating. Prior to addition of the 
peritoneal exudate cells, the plastic slide surfaces were coated with mouse 
serum albumin (1 mg/ml) or fibronectin (FN) from rat plasma (0.1 mg/ml) by 
a 60 min incubation at 20°C (115). The surfaces were washed three times with 
DPBS, incubated for 3 h at 37°C with the cells (0.25 ml/chamber). Where 
indicated phorbol dibutyrate (PDB) at 500 ng/m l was included during the 
plating of the cells. GBS strain COH31 was added to the macrophages as 
described for the adherence assay in the presence or absence of PDB (500 
ng/ml). Macrophage monolayers were exposed to these same sets of condi­
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tions without GBS to observe morphological changes in macrophage adher­
ence to the chamber-slide.
Results
Trypsin sensitivity o f the macrophage capacity to bind Group B streptococci 
The effect of trypsin on the capacity of macrophage monolayers to bind GBS 
was studied after treatment of the cells with increasing doses of trypsin. 
Macrophage monolayers were treated with 4.0,40,400 and 4000 (ig/ml of 
purified trypsin, washed twice with RPMI, incubated with aprotinin at 
concentration equimolar to the trypsin to inactivate the enzyme, washed 
again, and incubated under the usual conditions with 109 and 108/ml GBS. 
The number of microscopic Helds analyzed in order to determine the 
percentage of 1000 macrophages binding GBS was the same for the trypsin/ 
aprotinin-treated and aprotinin-treated (control) monolayers. The binding of 
five or more bacteria, which was exhibited by about 55% of the untreated 
macrophages, for each isogenic strain (Fig. 1), was relatively little affected by 
exposure to 4.0 pg/m l of trypsin. GBS binding fell to less than 40% after 
treatment with 40 pg/m l for each strain. Increasing the dose of trypsin 
further diminished the capacity of the macrophages to bind bacteria; and at 
trypsin concentratons of 4 mg/ml, less than 10% of the macrophages were 
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Fig. 1. Effect of trypsin treatment of Me on GBS binding. (A) strain COH31, 
(B) strain COH31/15, (C) strain COH31/21
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capsule, may be significantly less than the binding of wild-type COH31 by 
monolayers treated with 40 iig/ml although there are no apparent differences 
when monolayers are treated with higher doses of trypsin.
Effect of neutrophil elastaae on macrophage binding to GBS Macrophage 
monolayers were treated with increasing concentrations of neutrophil 
elastase over the range of 3.0 to 30 pg/m l and washed exhaustively with 
DPBS to remove the enzyme prior to the addition of wild-type COH31 GBS. 
Treatment of macrophages at each concentration of elastase had no effect on 
the percentage of macrophages binding five or more bacteria, determined by 
counting 1000 macrophages, when compared to bacterial binding by untreated 
macrophages. The percentage of macrophages binding five or more bacteria 
remained about 55%. In addition, there was no morphological change, at 
1000 X magnification, of the elastase-treated macrophage monolayers.
Effect o f 2-deoxy-D-glucose treatment o f macrophages on the binding o f GBS 
Macrophage monolayers were treated with 2-deoxy-D-glucose over the range 
of 0.5 to 500 mM for 2 h prior to the addition of bacteria as well as during the 
period of bacterial binding. Fig. 2 shows that approximately 55% of untreated 
macrophages bound five or more wild-type COH31 GBS, determined by 
counting 1000 macrophages. At the lowest concentration of 2-deoxy-D- 
glucose, 0.5 mM, there was a decrease in binding to 38% macrophages, 
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Fig. 2. Effect of pretreatment of Mo with the phagocytosis inhibitor, 2-deoxy-D 
glucose, on adherence of GBS to these cells.
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higher concentrations of 2-deoxy-D-glucose. A decrease in binding was 
maximal at 50 mM, resulting in less than 10% of the macrophages binding 
bacteria.
Temperature and divalent cation dependence o f GBS binding A study of the 
effect of temperature on the binding of GBS by macrophage monolayers 
revealed dramatic differences in the percentage of macrophages binding five 
or more bacteria. As shown in Fig. 3 binding was about 60% at 37°C. Binding 
was lowered three-fold to 22% at 20°C and was almost absent (3%) at 4°C.
There is an absolute requirement for either Ca?+ or Mg?+ to support adher­
ence of GBS to the macrophage monolayers as shown in Fig. 4. However, the 
presence of both cations, at 0.25 mM each, increased the percentage of macro­
phages binding bacteria from about 35% for either cation to 60%. This is the 
maximum binding I have ever achieved in any of my studies where DPBS 
was used during the incubation of GBS with the macrophage monolayers. 
DPBS (Sigma Chemical Co,) contains 0.9 mM Ca2+ and 0.5 mM Mg2+
Effect of phorbol ester and!or ligation of fibronectin receptors on GBS binding 
In this study I was investigating the effect of phorbol dibutyrate (PDB) on the 
ability of macrophages to bind GBS. In addition, I studied the effect of ligation 
of the macrophage fibronectin receptor, by itself or in combination with the 
presence of phorbol ester, on the binding of bacteria. Figure 5 depicts the 
effects of phorbol ester and ligation of the fibronectin receptor on the
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Fig. 5. Effect of phorbol ester and ligation of fibronectin receptor on binding of 






None Ponly P+B Bonly
Treatment
Fig. 5. Effect of phorbol ester and ligation of firbonectin receptor on binding of 
GBS to murine peritoneal Me. (A) binding to uncoated surface, (B) 
binding to albumin-coated surface, (C) binding to fibronectin-coated 
surface. KEY: none -  no phorbol ester present; P only = phorbol ester 
present only during the plating of Me; unbound ester removed prior to 
addition of bacteria; P & B = phorbol ester present during both plating 
of Me and incubation of Me with bacteria; B only -  phorbol ester 
present only during incubation of bacteria with Me
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percentage of macrophages binding five or more bacteria. When 
macrophages were allowed to adhere to an uncoated or albumin-coated 
surface, percent binding was similiar, about 55%. However, when PDB was 
present during the incubation of macrophages and bacteria with an uncoated 
or albumin-coated surface, the percentage binding almost doubled (94%). 
When PDB was present only during the plating of macrophages to the 
uncoated or albumin-coated surface of the slide and then washed away when 
non-adherent peritoneal exudate cells were removed, the percentage binding 
was lower (70%) than when PDB was present with bacteria, although this 
percentage binding was still higher than with no PDB treatment. When 
macrophages were plated on fibronectin-coated surface, with no PDB 
treatment, percentage binding as determined by the visual assay was 
maximal, 96%. The presence of PDB during plating only, during plating and 
binding or during binding only had no effect on the percentage macrophage 
binding GBS on a fibronectin coated surface. Thus both exposure to PDB 
during incubation of bacteria with Mo and ligation of the fibronectin receptor 
lead to an increase in bacterial binding to the Mo. If PDB is present during the 
plating of macrophages and then washed away, the effect of increased binding 
diminishes.
Morphological changes were observed for those macrophages plated on a 
fibronectin coated surface as compared with those attached to the albumin- 
coated or uncoated surfaces. The cells appeared to be covering a greater
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surface area per cell and to be more stellate in shape. The cytoplasm to 
nucleus ratio was increased, so that attached or internalized bacteria were 
much more visible.
Discussion
A number of studies have been described in this paper on the effect of 
various enzymes, chemical treatments and temperature on the binding of 
GBS to monolayers of murine peritoneal macrophages in the absence of 
serum. The purpose of these experiments was to elucidate a mechanism of 
non-opsonin-mediated recognition of bacteria by phagocytic cells in order to 
have a better understanding of our innate host defenses. Innate immunity is 
particularly important for individuals in which the immune system may not 
be operating optimally, for example in geriatric individuals, infants, indivi­
duals with a compromised lymphocyte immunity, and for certain sites in the 
body such as the lungs in which low serum opsonin concentrations may not 
be sufficient to effectively opsonize many bacterial species (28). Previous 
studies in our laboratory have demonstrated that this binding is not mediated 
by the interaction between galactose exposed on GBS and the galactose recep­
tor on the macrophage (see Chapter 2).
The trypsin sensitivity of the macrophage mechanism involved in the 
recognition of GBS is compatible with the function of a membrane protein.
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This recognition mechanism appears to be distinct from known macrophage 
receptors such as the Fc receptor and the C3b receptor, CR1, whose activities 
are resistant to trypsin digestion (36). In addition, in Fig. 1 1 observed that the 
presence of capsule or exposure of terminal galctose on the GBS had no effect 
on macrophage binding. Working on the assumption that bacterial binding 
was mediated by a Me membrane protein, I attempted to identify this receptor 
by comparing parameters of this binding with those of known macrophage 
receptors.
Neutrophil elastase has been implicated as a factor that impairs local host 
defenses in chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. 
Tosi et al. (100) showed that this enzyme cleaves CR1 from neutrophils 
(PMN) in the lungs of infected patients. The C3bi receptor on these cells, CR3, 
is resistant to elastase. My studies with treatment of macrophage monolayers 
by increasing concentrations of elastase demonstrated no reduction in the 
binding of GBS at levels as high as 30 pg/m l. CR1 is sensitive to elastase at 
10 ng/m l (100). Neutrophil elastase has been shown to cleave other phago­
cytic receptors including the Fc receptor (99).
Two-deoxy-D-glucose has been shown to inhibit Fc and CR3-mediated 
phagocytosis of mouse peritoneal macrophages but not mannose receptor- 
mediated phagocytosis (97). Phagocytosis does not require protein synthesis 
and protein glycosylation, processes interrupted by accumulation of metabo­
lites of 2-deoxy-D-glucose in the cell. The mechanism of 2-deoxy-D-glucose
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inhibition of phagocytosis is distinct and may involve a complex series of 
events resulting from a depolarized macrophage, a lowered cellular energy 
reserve, and may also involve the imbalance in the intracellular pool of ions 
critical for phagocytosis (97). Of interest is the finding that despite the large 
area of plasma membrane internalized by the macrophage during phago­
cytosis, concomitant protein synthesis is not required. Part of this may be due 
to the ability of macrophages to recycle their membrane proteins (54). There 
are also large numbers of membrane vesicles in the macrophage to replenish 
the internalized membrane (87).
The method used in this study for visual quantitation of GBS recognition 
by macrophage monolayers cannot differentiate between attached and inter­
nalized bacteria. Numbers of internalized bacteria are therefore included in 
the data as bound bacteria. Since binding is allowed to occur at 37°C and the 
macrophages are viable, macrophages with phagocytosed bacteria probably 
contribute to the number of cells scored as positive for binding five or more 
bacteria. Therefore, the property of dose-dependent inhibition of binding of 
GBS observed in our studies for 2-deoxy-D-glucose may involve CIO, which 
has been implicated in the direct binding of other pathogens (115).
The characteristics of temperature and divalent cations on the binding of 
GBS to macrophage monolayers were studied. Binding required either Ca*+ 
or Mg2+ and increased by 50% if both cations were present. This was not the 
result of a higher total concentration of ions; the total concentration of cation
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present either individually or jointly was 0.5 mM. Binding was also tempera 
ture dependent with maximum binding occuring at 37°C. The requirements 
for divalent cations and warm temperatures are unlike those for the binding 
of lectin receptor (I. Ofek, personal commun.) and IgG or C3b-coated particles 
(116). However, these characteristics closely resemble the requirements for 
binding of particles by CR3 (112).
Receptors for the third component of complement (C3) on cultured 
human monocytes bind ligand-coated particles but do not initiate phago­
cytosis (32). The function of these receptors, however, is altered dramatically 
after monocytes attach to surfaces coated with fibronectin or after monocytes 
are exposed to phorbol esters. Fn and phorbol esters "activate" C3 receptors 
such that they promote vigorous phagocytosis (116). There is no evidence 
that Fc or lectin-like receptors are affected by these treatments. In my adher­
ence assay, bacteria that have been internalized by phagocytosis probably 
contribute to the number of macrophages observed to bind five or more 
bacteria, therefore I studied the effect of macrophages treated with phorbol 
esters or plated on a fibronectin-coated surface on the binding of GBS.
In summary I have shown that ligation of FN receptors causes enhanced 
"binding" of GBS to macrophages. The effect of ligated FN receptors on the 
increase numbers of GBS associated with the macrophages can be mimicked 
by PDB. The effect of PDB on increased binding of GBS by macrophages was 
shown to be reversible when the phorbol ester was removed. PDB was used
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in these studies instead of the more hydrophobic phorbol myristate acetate 
(PMA) since more than one-half of cell-associated PDB may be released from 
the cells upon washing 20°C (29).
This study confirms that a macrophage membrane receptor is involved in 
the binding of GBS in vitro. Table 1 summarizes data from my studies and 
others in comparing the effects of temperature, elastase, 2-deoxy-D-glucose, 
phorbol ester, ligation of FN receptors and divalent cation requirements with 
known macrophage receptors. A comparison of binding characteristics for the 
macrophage Fc receptor, galactose-receptor and integrin receptor for C3bi, 
suggest a similiarity between CR3 and the receptor for GBS.
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TABLE 1
PROPERTIES OF KNOWN BACTERIAL RECEPTORS ON M0
Properties Receptors
GBS* Integrin Lectin Fc
Temperature dependence + + (116)b -  (105) -  (116)
Trypsin sensitivity + + (16) -  (105) -(16)
Elastase resistance + + (100) ? -(99)
Ca2+ and Mg2+ requirement - -  (116) +(105) + (116)
Ca2+ or Mg2+ requirement + + (116) -(105) -  (116)
2-deoxy-D-glucose inhibition + + (97) -(97) + (97)
FN-substrate enhancement + + (114) -  (114) -  (114)
Phorbol ester enhancement + +(114) -  (114) -  (114)
a data from this study 
b results compiled from references dted
CHAPTER 4
ROLE OF fc INTEGRINS AND LIPOTEICHOIC ACID IN THE ADHERENCE 
OF GROUP B STREPTOCOCCI TO MURINE PERITONEAL MACROPHAGES
Abstract
The type EH group B streptococcus (GBS), an extracellular pathogen, is 
recognized by murine peritoneal macrophages (Mo) in the absence of serum 
components such as complement or antibody. To understand this non­
opsonin mediated adherence of GBS, I have investigated the role of die Me 02 
family of integrin receptors, CR3, LFA-1 and pl50,95, and the bacterium- 
bound ligand, lipoteichoic add, in the mechanism of adherence. Two mono­
clonal antibodies that bind to either subunit of murine CR3, M l/70 and 
M18/2, inhibited adherence of GBS to Me; attachment was inhibited by 31 
and 66% by M l/70 and M18/2, respectively. The interaction between GBS and 
CR3 probably does not involve the C3bi-binding site on CR3, however, 
because a monoclonal antibody which exhibits spedfidty for this site, M l/70, 
inhibited GBS attachment by only 31%. In contrast, M18/2, which reacts with 
the 0 subunit common to all members of this integrin family, inhibited 
ingestion by 66%. The effect of using both monoclonal antibodies was not
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additive. Downmodulation studies using the same antibodies, separately and 
in combination, to deplete the receptors from the apical surface of adherent 
Me were performed to examine their effect on GBS adherence. Similiar 
results were obtained. Results from flow cytometry studies using these same 
antibodies in solution with a mixture of suspended bacteria and Mo also 
showed similiar inhibition profiles. One monoclonal antibody, 5C6, that 
ligates a different epitope on the a-subunit of CR3 from M l/70, did not 
produce an inhibitory effect on the adherence of GBS to Me by flow cyto­
metry. I was unable to use this antibody in downmodulation studies or 
inhibition studies requiring a Me monolayer because this antibody recog­
nizes a M g2+ -dependent anchorage site on the Me.
A dose-dependent effect of LTA to inhibit the binding of GBS to Me was 
observed in all studies using LTA; downmodulation of Me receptors by LTA, 
LTA in solution with Me monolayers or in flow cytometry studies with 
suspended cells. Inhibition of GBS adherence to Me was maximal (70%) at a 
concentration of 30 tig/m l.
My studies suggest the role of LTA and the fe integrins in the binding of 
GBS by murine peritoneal Me. Recognition of phosphosugar surface struc­
tures on the extracellular pathogen, GBS, is consistent with other studies 
suggesting that a similar surface struture on both intracellular and extracel­




Adhesion between phagocytes and other cells, particles, or the extracellular 
matrix is crucial for a variety of functions such as phagocytosis, diapedesis, 
and positioning of phagocytes in the liver, lungs, and other tissues (103). 
Phagocytosis represents an important effector mechanism for the eradication 
of infectious agents. It is performed primarily by specialized cells of two 
different lineages, namely polymorphonuclear neutrophilic granulocytes 
(PMN) and mononuclear phagocytes (Me). Because of their major function, 
these cells are often referred to as 'professional phagocytes' to distinguish 
them from most other host cells which are called 'non-professional phago­
cytes'. To fulfill these functions, PMN and Me must respond to specific 
signals that indicate the presence of infectious agents and also collaborate 
with the elements of specific immunity. Phagocytosis alone cannot eradicate 
invading microbes, it must be followed by intracellular killing mechanisms 
using specialized organelles and molecules. It has long been assumed that 
PMN and Mo have specific receptors for binding microorganisms directly 
and specific receptors that mediate cellular adhesions, but only recently have 
such receptors been isolated and characterized.
The idea that a few receptors could be responsible for a wide range of 
adhesion events first arose with the discovery of a class of patients that exhibit 
recurrent life-threatening infections with gram-positive, gram-negative and
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fungal pathogens (5). These patients exhibit extreme leucocytosis but fail to 
form pus at sites of infection. In vitro experiments showed that PMN from 
these patients are defective in their ability to adhere to C3bi-coated erythro­
cytes, to protein-coated glass or plastic surfaces (3), and to endothelial cells 
(34), and that failure to adhere results in the inability to display chemotactic 
responses. Thus, susceptibility to infection probably results both from an 
inability to bind and ingest opsonized pathogens and a failure to recruit cells 
to sites of infection. Additionally, these observations suggest that the leuco­
cytes of patients fail to extravasate and are retained in the vasculature by a 
failure to adhere to endothelial cells, giving the name of leucocyte adhesion 
deficiency (LAD) to this condition. Characterization of the proteins missing 
from the patients' leucocytes have confirmed their role in adhesion to endo­
thelium and in several other adhesion events.
LAD is caused by a failure of leucocytes to express three related proteins, 
LFA-1, CR3 and p i50,95, of the integrin family of cell-cell and cell-matrix 
proteins (90). Each of these cell-surface glycoproteins consists of an a i Pi 
dimer composed of a 150,-190,000 Mr a  chain and a 95,000 Mr f) chain, 
schematically depicted in Fig. 1. The f) chain is identical in each of these three 
proteins (77) and has been given the designation CD18 by the International 
Workshop on Leucocyte Antigen Differentiation. The a  chains are struc­
turally and antigenically distinct (113). The a  chains of LFA-1, CR3 and
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Fig. 1. Schematic structure of an integrin. Taken from Steven M. Albelda
and Clayton A. Buck. 1990. Integrins and other cell adhesion molecules. 
FASEB J. 4:2868-2880.
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pl50,95, are termed C D lla, C D llb and C D llc, respectively, and CR3 is referred 
to as CDllb/CD18.
LAD patients are deficient in all three of these proteins because of an 
inherited defect in the p chain (90). Cells from LAD patients do synthesize 
normal precursors of the a  chains, but these precursors are very rapidly 
degraded and do not appear on the cell surface. Patients have recurring 
infections, often fatal in childhood unless they are corrected by bone marrow 
transplantation. In a study by Ross et al. (73), children with LAD had 
recurrent skin infections with Staphylococcus epidermidis but not yeast 
suggesting the role of CR3 and LFA-1 in the phagocytosis of unopsonized 
bacteria.
Lymphocytes express abundant LFA-1, but neither CR3 or pl50,95. PMN 
express abundant CR3, whereas LFA-1 and pl50,95 are minor but easily 
detectable components. Macrophages express large amounts of all three of 
these proteins. Expression of these proteins appears to be restricted to 
leucocytes; they have not been found on other mammalian cell types.
The first molecule shown to be deficient from LAD patients (5) had been 
previously identified as a receptor for a cell-bound fragment of complement 
(114) and was named CR3 (complement receptor type three). CR3 has also 
been referred to as Mac-1 and Mol because it was the first phagocyte-specific 
antigen identified by monoclonal antibodies in mouse and man, respectively. 
CR3 functions as an opsonic receptor, and promotes the binding of C3bi­
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coated cells and particles by monocytes, macrophages and PMN (112,117). In 
appropriately stimulated cells, binding is followed by phagocytosis of the 
particle but does not induce reactive oxygen metabolites (21). Therefore, CR3 
provides a safe way for entry into professional phagocytes, compared to inter­
nalization via the Fc receptor. Most intracellular pathogens except viruses, 
have been shown to use CR3 for entry into mononuclear phagocytes. Exam­
ples are Legionella pneumophila, (63) Mycobacterium tuberculosis, (64), 
Leishmania sp. (98), and Histoplasma capsulatum (12).
CR3 requires relatively high concentrations of divalent cations (about 0.5 
mM Ca?+ and Mg?+) in order to interact effectively with ligand (112). Integrin 
a-subunits have three or four tandem repeats of a putative divalent cation- 
binding motif, and have been shown to require Ca2+ or Mg2+ for function (91). 
This behavior contrasts with that of other opsonic receptors (CR1 and FcR) 
which do not require divalent cations for binding activity. In addition, the 
binding capacity of CR3 is temperature dependent, and is absent in cells held 
at 0°C (117), again distinguishing CR3 from other opsonic receptors (CR1 and 
FcR) which bind well at 0°C.
In the presence of serum, most pathogens are taken up via C3bi deposi­
tion on their surface. CR3 does not recognize either the precursor C3b, or the 
product of further cleavage C3dg (14, 72,112). Binding of monomeric or 
dimeric C3bi to CR3 has not been reported, presumably because of low bind­
ing affinity. Studies using sheep erythrocytes coated with 104 to 105 C3bi per
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cell demonstrate avid binding to CR3-bearing cells presumably because of 
multivalent interaction with the phagocytes. By analogy, it is likely that LFA- 
1 and p i50,95 also bind their targets with low affinity and that adhesion 
events mediated by these receptors are driven by multivalent interactions. A 
functional consequence of low affinity binding is the potential to reverse 
adhesion and promote detachment.
CR3 has two distinct binding sites. One is located on the a  chain and binds 
ligands such as C3bi, containing the Arg-Gly-Asp (RGD) sequence. In the 
absence of C3bi, microorganisms expressing a surface protein containing the 
RGD sequence could bind to CR3. For example, Bordetella pertussis, a gram- 
negative coccobacillus and the causative agent of whooping cough, has been 
shown to adhere to human macrophages, in vitro. The interaction between 
macrophage CR3 and B. pertussis filamentous hemagglutinin (FHA) 
involves recognition of the RGD sequence at positions 1097-1099 in FHA (68).
The other binding site on the a  chain of CR3 has a lectin-like character 
and, for example, recognizes lipopolysaccharide (LPS) located on the outer 
leaflet of the outer membrane of Escherichia coli (116). Histoplasma 
capsulatum binds directly to CR3 via the lectin-like binding site (12). In 
addition, an abundant surface glycolipid, promastigote lipophosphoglycan 
(LPG), from Leishmania has been shown to bind to the lectin-like-LPS' 
binding site on the a  chain of QR3 (76,98). It is possible that LPS, LPG and H. 
capsulatum display a common structure, such as a sugar phosphate, that can
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be recognized by CR3 (116).
Characterization of the non-opsonic binding parameters of Group B 
streptococci (GBS) and murine peritoneal macrophages in our laboratory (see 
Chapter 3) has suggested a similiar binding profile for the 'GBS-receptor' and 
CR3, based on divalent cation and temperature dependence, trypsin sensiti­
vity, elastase resistance and 2-deoxy-D-glucose inhibition. Group B strepto­
cocci contain membrane teichoic acid, lipoteichoic add  (LTA) which is known 
to mediate the adherence of GBS to human embryonic, fetal and adult epithe­
lial cells (55). Hydrophobic interactions due to the lipid fatty add portion of 
the polymer and possibly other cell surface components within the plasma 
membrane of embryonic and fetal cells has been suggested as a mechanism 
for adherence. Interaction of the glycerol phosphate backbone with specific 
receptor sites on the cell may follow or occur independently for the attach­
ment of GBS to adult cells (55). The teichoic add moiety of GBS LTA (55) and 
Group A streptococd LTA (58) has been implicated in the ability of these 
microorganisms to adhere to neonatal tissue. Competition binding experi­
ments using soluble LTA may help to confirm if a structure such as a sugar 
phosphate, common to LTA, LPS, and LPG in involved in the binding of GBS 
to murine peritoneal macrophages. Positive evidence would support the 
theory that the GBS receptor is CR3.
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Materials and Methods
Chemicals All chemicals were obtained from Sigma Chemical Co, (St. Louis, 
MO) unless otherwise noted.
Bacteria Type m  Group B streptococci, designated as strain COH31, was kindly 
provided by Dennis Kasper, Channing Laboratory for Infectious Disease 
(Harvard Medical School). This strain was originally isolated from infants 
with meningitis (44). It was grown and maintained in our laboratory as 
previously described (see Chapter 2).
Assay o f GBS adherence Monolayers of macrophages (prepared as previous­
ly described in Chapter 2) were layered with 0.2 ml of GBS at densities of 
10io/ml and 10* /m l in DPBS and incubated at 37°C in the CO2 chamber for 1 
h as previously described (see Chapter 1).
Hybridoma lines and MAh The characteristics of the antibodies used in this 
study are summarized in Table 1. The derivation of rat anti-mouse subdoned 
lines of Ml/70.15.11.5 (89), M 18/2a.l2 (78) and 5C6 (71) has been previously 
described. The sub-clones Ml/70.15.11.5 (ATCC TIB 128) and M18/2a.l2.7
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TABLE 1
RAT ANTI-MOUSE MAb TO 02 INTEGRINS
MAb Origin Epitope Isotype
Ml/70.15.11.5a T. A. Springer 
(89)
a  subunit of CR3, 
inhibits C3bi binding
IgG2b
5C6 S. Gordon (71) a  subunit of CR3, inhibits 
Mg2if -dependent binding
lgG2b
M18/2a.l2.7a T. A. Springer 
(78)
02 subunit of CR3, LFA-1, 
and pl50,95
IgG2a
a purified from hybridoma supernatants by protein G affinity 
chromatography.
90
(ATCC TIB 218) were obtained as frozen suspensions (American Type Culture 
Collection, Rockville MD). For brevity, these subdones will be designated as 
Ml /70 and M18/2. The 5C6 antibody was purchased as purified IgG from 
Serotec (Kidlington, Oxford, designated as MCA 711).
To obtain large quantities of purified MAb, the hybridoma line of M l/70 
was grown in Dulbecco's modified Eagle's medium (D-MEM) with 4.5 g/L  
glucose and the M18/2 line was grown in RPMI1640, with 5 x 10*5 M 2-mercap- 
toethanol. Both media were supplemented with 10% low IgG fetal bovine 
serum (Hyclone Laboratories, Logan, Utah), 2mM L-glutamine and penicillin- 
strep tomyrin. The cell lines were grown in 75 cm2 flasks, at 37°C in a humidi­
fied atmosphere of 5% CO2 and 95% air, to densities exceeding lOVml to 
exhaust the media. The supernatant, containing secreted antibody, was 
removed from the cells by centrifugation (100 xg). MAb were purified by 50% 
saturated (NH^SC^ precipitation and affinity chromatography on Protein G 
Superose® 4 Fast Flow (Pharmacia LKB Biotechnology, Piscataway, NJ) 
equilibrated with 20mM phosphate-buffered saline, pH 7.0 (PBS), containing 
0.1% thimerosal. The IgG was eluted with 0.1 M glycine, pH 2.7, and collected 
as 1.5 ml fractions in tubes containing 45pl 1.0M Tris-HCl, pH 9.0 to preserve 
the activity of the add labile IgG. Column size and flow rates were deter­
mined by the rat IgG2a and IgG2b binding properties quoted in the data sheet 
accompanying the affinity chromatography product.
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Lipoteichoic acids Purified and lyophilized lipoteichoic add  from Strepto­
coccus pyogenes (group A streptococci) prepared in the laboratory of the late 
Edwin H. Beachey, University of Tennessee (Memphis, TN) was kindly pro­
vided by Itzak Ofek, Tel Aviv University (Tel Aviv, Israel). Purified LTA 
from Streptococcus agalatiae GBS was kindly provided by Stephen J. 
Mattingly, University of Texas, (San Antonio, TX). Solutions of each type of 
LTA at 10 m g/m l were prepared in sterile water to prevent deacylation. The 
LTA was diluted into DPBS, pH 7.2, immediately before use to the concen­
trations desired for the inhibition assays.
Inhibition studies using MAbs or LTA Macrophage monolayers were 
preincubated for 30 min at 37°C with soluble MAbs or LTA in DPBS before 
the addition of bacteria to study their effect on GBS adherence to peritoneal 
macrophages. Solutions containing various MAbs, alone or in combination, 
each at a final concentration of 10 and 50 jig/m l, or LTA at 75,150,300 pg/m l 
were added to the monolayers. Normal rat IgG and FBS were used as nega­
tive controls for the antibody studies. The effect of group A streptococcal LTA 
on binding was also studied by co-incubation of the monolayers with bacteria 
and the LTA, without the head start'.
Downmodulation Studies The ability of solid phase MAb to down-modulate 
macrophage CR3 and inhibit GBS binding was examined by coating 8- 
chamber glass slides (Lab-Tek) with the MAbs, alone or in combination, at
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concentrations of 10 and 50 |i.g/ml in 0.1 M carbonate-bicarbonate, pH 9.6 
overnight at 4°C. The effect of macrophages adhering to a surface coated with 
group B streptococcal LTA on bacterial binding was also studied. Since LTA 
contains both hydrophobic and hydrophilic regions, I allowed LTA to adhere 
to both plastic and glass slides for my studies of inhibition of adherence. It 
was possible that one of these surfaces would provide a better substrate for 
LTA, based on its different regions. The slides were coated overnight at 4°C 
with DPBS containing LTA at 30,300 and 3000 ng/m l. After removing 
unbound MAbs or LTA with DPBS, peritoneal exudate cells were added to 
these slides as described above to prepare macrophage monolayers. Bacteria 
were added to these slide for the binding assay. Rat IgG and FBS were used to 
coat slides as negative controls for inhibition.
Flow cytometry To examine the adherence of GBS by macrophages in suspen­
sion, flow cytometric analysis of fluorescent GBS bound to macrophages was 
performed by the use of a FACStarPLUS (Becton Dickinson, FACS Systems, 
Sunnyvale, CA) with computer-assisted evaluation of data (FACStarn-us 
Lysys II software). To label the bacteria with a fluorochrome, I chose Lucifer 
Yellow VS. Lucifer Yellow (LY) (95) is the vinyl sulfone derivative of a 
sulfonated 4-amino napthalimide molecule with spectral properties similiar 
to the more commonly used fluorescein isothiocyanate. Unlike the fluore­
scein, however, the fluorescence intensity of LY is stable from pH 2 to pH 10.
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Thus, LY fluorescence is unaffected by pH changes achievable in endocytic 
vesicles or lysosomes (48). When LY was linked covalently to amino and 
sulfhydryl groups on the surface of Streptococcus pneumoniae, Sveum et al. 
(95) reported quantitation of macrophage-associated bacteria at all stages of the 
adherence and ingestion phases of phagocytosis.
Labelling of bacteria was achieved by incubating 1010 GBS and 1 mg of 
Lucifer Yellow VS (LY) in 1.0 ml of 0.1 M NaHCOa, pH 9.5, for 2 h at room 
temperature, then washing the cells five times in DPBS (95). Washed perito­
neal exudate cells containing 95% macrophages at 2 x 106/m l and LY-GBS at 
10®/m l, in DPBS, were incubated for 1 h at 37°C to allow for binding to occur. 
Cells were fixed by addition of an equal volume of 2% formaldehyde and 
samples were either examined immediately or stored at 4°C for up to two 
weeks before analysis by flow cytometry.
The effect of MAb or GBS-LTA on adherence of GBS was investigated by 
preincubating the macrophages for 30 min at 37°C with MAb M l/70, M18/2 
or 5C6, at 10 and 100 pg/m l, or LTA at 30 and 300 pg/m l, before the addition of 
bacteria. The emission of Lucifer Yellow-labeled GBS attached to macro­
phages was recorded at 530 nm after excitation by the argon laser at 488 nm. 
Data were acquired by using an instrument status with a linear data mode for 
Forward Scatter (FSC) and Side Scatter (SSC) and a logarithmic data mode for 
Filter 1 (Fll) for 530 nm. The FSC threshold was raised to eliminate unbound 
bacteria, red blood cells, platelets and and a live gate was set around the macro-
94
phages in the control.
The Kolmogorov-Smimov (K/S) Two-Sample Test was used to test for 
inhibition of bacterial adherence to macrophages by MAb or LTA. K/S 
calculates the probability that two histograms are different by computing the 
summation of the curves and finds the greatest difference between the 
summation curves.
Results
A  macrophage fa  integrin mediates adherence o f group B streptococci To 
explore the role of the macrophage fc integrins in mediating adherence of 
GBS to peritoneal macrophages, I examined the capacity of MAb directed 
against either subunit to inhibit bacterial adherence. The cumulative data 
from two experiments, using soluble antibodies and macrophage monolayers, 
are shown in Table 2. MAb M18/2, directed against the ^-subunit CD18 
common to all three members of the 02 integrins, significantly inhibited GBS 
adherence. Monoclonal antibody M l/70, directed against the C3bi binding 
site on the a-subunit, C D llb, also inhibited GBS adherence but to a lesser 
degree. The mean inhibition for M18/2 was 66% and mean inhibition for 
M l/70 was 31%. When the antibodies were used in combination the mean 
inhibition was 70%. When the monoclonal antibody 5C6, with specificity for 
the Mg2+ -dependent anchorage site on C D llb, was tested for its effect on
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TABLE 2
INHIBITION OF STREPTOCOCCAL ADHERENCE TO Mo BY 
MONOCLONAL ANTIBODIES
Antibodies Used Percent p Value**
Inhibition*
M l/70 M18/2 Polyclonal IgG
— — — 0 0 —
- - + 3 3 —
- + - 64 67 0.006
+ - - 33 28 0.008
+ + 67 72 0.001
* Results of two separate experiments
b Based on analysis of variance, p Values based on comparisons between 
effect of each MAb and IgG control. There was no significant difference 
between IgG control and control with no antibody added. There was no 
significant difference between the effect of M l/70 alone and in combina­
tion with M18/2 (p = 0.304).
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inhibition of GBS adherence, the macrophages appeared to become less 
adherent and many were removed from the surface of the slide with the 
subsequent washings. Therefore, whenever this antibody was included in my 
tests I was unable to obtain results for its effect on macrophage binding of 
GBS. Control antibody, polyclonal rat IgG, did not significantly inhibit GBS 
adherence (mean inhibition, 3%).
Downmodulation studies using antibodies M l/70 and M18/2 demon­
strated a similar inhibition profile. As shown in Table 3 the mean inhibition 
of GBS adherence for macrophages attached to a M18/2 -coated surface, from 
two experiments, was 59% and the mean inhibition for M l/70 was 28%.
When both antibodies were used, mean inhibition was 62%. Macrophages 
attached to the glass slide coated with MAb 5C6 appeared to be very unstable. 
The cells were not well attached (i.e., they appeared rounded up) and were 
easily removed by washing with DPBS. Therefore this antibody was not used 
in the downmodulation studies. When macrophages were allowed to attach 
to a polyclonal rat IgG-coated surface there was no significant inhibition of 
GBS binding.
When flow cytometry was employed to study the binding of GBS to macro­
phages it was possible to quantify bacterial binding without having to wash 
away unbound bacteria. Figure 2 compares the fluorescence intensity of 
unstained GBS with that of LY-labelled GBS. For this method we kept the 
macrophages in suspension by using siliconized microcentrifuge tubes;
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TABLE 3






IgG polyclonal 3 3 —
M l/70 CR3 a  chain 26 30 0.006
M18/2 fc chain 57 61 0.001
M1/70 + M18/2 a  and fe chains 60 64 0.001
* Results of two separate sets of experiments. Positive binding: S 5 
bacteria/M 0. 1000 M 0 counted for each entry 
b Based on analysis of variance, p Values based on comparisons between 
effect of each MAb and IgG control. There was no significant difference 
between IgG control and control with no antibody added. There was no 
significant difference between the effect of M l/70 alone and in combina­




Fig. 2. Fluorescence histograms of unlabeled and LY-labeled group B 
streptococci.
99
therefore I was able to test the effect of MAb 5C6 (against the anchorage- 
dependent site) on the binding. Figures 3-5 are overlays of fluorescence 
histograms comparing the FSC with fluorescence intensity, for unstained GBS 
binding to macrophages, with maximum fluorescence of LY-labelled GBS 
binding to macrophages as well as the effect of MAb M 18/2, M l/70, and 5C6 
on the fluorescence intensity of the GBS-bound macrophage.
The K /S statistic, D/s(n), is an index of similarity for two curves. [s(n) = 
square root of (ni + n2)/(n i * n2>, where ni is the number of events in the 
first histogram; n2 is the number of events in the second histogram] If D /s(n) 
= 0, the curves are identical. A value of 5.0 or greater indicates a statistically 
significant difference between two curves. Table 4 summarizes the D/s(n) 
statistic for each concentration of MAb. Monoclonal antibody M l/70, recog­
nizing C D llb  ((Xr,-subunit) and M18/2, recognizing CD18 ({)-subunit) each 
inhibited the adherence of GBS to macrophages. The monoclonal antibody 
5C6, recognizing a different epitope on C D llb was not inhibitory. These data 
are consistent with downmodulation and soluble inhibition studies using 
MAbs, supporting the role of fc integrins in the binding of GBS.
The role o f LTA in the recognition o f GBS by peritoneal macrophages The 
effect of soluble LTA from group A and group B streptococci on GBS binding 
by macrophage monolayers was studied in two separate experiments. Figure 
6 shows the cumulative data from both studies. For my first studies only
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M W 0  I N H I B I T I O N
MACS + UN GBS
\ MACS + GBS
\
V M l/7 0  100 UG/ML
M l/7 0  10 UG/ML
75*
Fig. 3. Effect of monoclonal antibody M l/70 on adherence of LY-labeled GBS 
and Me. Overlay of histograms for controls: Me + unlabeled GBS 
demonstrates inherent fluoresecence of Me; Me + LY-labeled GBS 
demonstrates maximum fluorescence intensity without antibody.
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M l 8 ^ 2  I N H I B I T I O N
MACS + UN GBS
M l8 /2  100 UG/'ML 
\ \  Ml 8 /2  10 UG/'ML
74-
Fig. 4. Effect of monoclonal antibody M 18/2 on adherence of LY-labeled
GBSand Me. Overlay of histograms for controls: Me + unlabeled GBS 
demonstrates inherent fluoresecence of Me; Me + LY-labeled GBS 
demonstrates maximum fluorescence intensity w ithout antibody.
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5 C 6  I N H I B I T I O N
MACS + UN GBS
\  MACS + GBS 
I  5C6 100 UG^ML 
\ V \  5C6 10 UG/ML
f j
Fig. 5. Effect of monoclonal antibody 5C6 on adherence of LY-labeled GBS and 
Me. Overlay of histograms for controls: Me + unlabeled GBS 
demonstrates inherent fluoresecence of Me; Me + LY-labeled GBS 
demonstrates maximum fluorescence intensity w ithout antibody.
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TABLE 4
KOLMOGOROV-SMIRNOV ANALYSIS OF FLUORESCENCE HISTOGRAMS 
ASSESSING THE EFFECT OF MONOCLONAL ANTIBODIES TO 
LEUKOCYTE INTEGRINS ON BINDING OF GROUP B STREPTOCOCCI TO 
MURINE MACROPHAGES
Concentration Monoclonal Antibody
M l/70 M18/2 M5C6
10 Mg/ml 11.67*® 3.23 1.75
100ng/ml 10.65* 10.05* 2.68
® Numbers refer to D/s(n) values. See text for details. Values greater than 5.0 
are considered statistically significant and are noted by an asterisk.
0 100 200 300
LTA (jig/ml)
GBS LTA: HEAD START 
GAS LTA + COH 31 
GAS LTA: HEAD START
Fig. 6. Inhibition of bacterial binding to Me by lipoteichoic add
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group A streptococcal (GAS) LTA was tested. GBS binding by macrophage 
monolayers pre-exposed to this LTA were compared with monolayers 
exposed to LTA only during the incubation with bacteria. When macro­
phages are preincubated ('head-start') with GAS-LTA, there was a greater 
effect on inhibition of bacterial binding than when macrophages were 
exposed to LTA only in the presence of bacteria. A second study showed a 
similiar dose-dependent inhibitory effect on the binding of GBS when the 
macrophages were pre-exposed to LTA from GBS as well (Fig.6).
To further examine the role of LTA in the binding of GBS, macrophages 
were allowed to adhere to glass or plastic surfaces coated with LTA from 
group B streptococci. By analogy with the downmodulation studies using 
monoclonal antibodies to CR3, specific receptors for LTA would be expected to 
diffuse to the substrate-attached portion of the macrophage, where they are 
trapped by interaction with the surface-bound LTA, leaving the apical surface 
of the cells devoid of LTA receptors. As shown in Fig. 7 GBS binding to 
macrophages was inhibited to a high degree (>60%) when either glass or 
plastic slides were coated with LTA at concentrations of 30 pg/m l or greater, 
suggesting the existence of a receptor on the macrophage that recognizes LTA.
When flow cytometry was used to observe the effects of LTA on the ability 
of macrophages to bind GBS, I obtained results that were consistent with the 
previous downmodulation and inhibition studies. Figure 8 is an overlay of 






n 0  glass slide 
■  plastic slide
LTA (n g/m l)
Fig. 7. Effect of downmodulation of LTA receptors on bacterial binding 
by Mo
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LTA I N H I B I T I O N
MACS + UN GBS
MACS + GBS
LTA 300 UG/ML 
1 Y , LTA 30 UG/ML
Fig. 8. Effect of lipoteichoic add on adherence of LY-labeled GBS and 
Me. Overlay of histograms for controls: Me + unlabeled GBS 
demonstrates inherent fluoresecence of Me; Me + LY-labeled GBS 
demonstrates maximum fluorescence intensity w ithout LTA.
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unstained GBS binding to macrophages with maximum fluorescence of LY- 
labelled GBS binding to macrophages as well as the effect of LTA on the 
fluorescence intensity of the GBS-bound macrophage. The D /s(n) statistic for 
LTA at 30 pg/m l was 1.17, indicating no significant difference from the 
untreated system. Significant inhibition of GBS binding to macrophages, 
however, was observed for a concentration of LTA at 300 pg/m l (D/s(n) = 
10.49). These data are consistent with downmodulation and soluble inhibi­
tion studies using LTA, supporting the role of LTA in streptococcal recogni­
tion by the macrophage.
Discussion
Macrophages can recognize group B streptococci in the absence of IgG and 
complement proteins. I show here that a family of three structurally related 
receptors on macrophages, CR3, LFA-1 and pl50,95, are involved in recogni­
zing group B streptococci. When a monoclonal antibody, M l/70, that recog­
nizes the a-subunit of CR3 was added to macrophages or used to downmodu- 
late or ligate CR3 on macrophages, the binding of GBS was reduced (Table 3). 
The binding of GBS may be reduced to a greater degree when a monoclonal 
antibody, M18/2 that recognizes the ^-subunit, common to all members of 
the family, is used in these same studies. The monoclonal antibody 5C6, that 
recognizes a different epitope from M l/70 was not inhibitory. These results
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suggest two possibilities for the GBS receptor on macrophages. Either the 
receptor is CR3 and the binding site is located near the epitope recognized by 
M18/2 on the ^-subunit or all three members of the family of integrins, 
CR3, LFA-1 and pl50,95, are involved. This mechanism of recognition may 
thus serve in the initial response of cells to bacteria, before the generation of 
specific immunity. Consistent with this view are the observations on several 
patients whose cells lack the common (1-chain of CR3, LFA-1 and p i50,95 and 
thus express none of the mature dimers on their cell surface (26). These 
patients suffer recurrent infections (73).
Wright and Jong (116) have shown that each of the three structurally 
related receptors on macrophages, CR3, LFA-1 and pl50,95, is capable of recog­
nizing E. coli. Their observations suggest that the receptors must bind the 
hydrophilic portion of lipopolysaccharide that extends from the E. coli 
membrane. Since the hydrophilic protion of lipid IVa is composed of 
diglucosamine bisphosphate, the authors suspect that a disaccharide or sugar 
phosphate provides the structure that is recognized. It is possible that the 
three proteins, CR3, LFA-1, and pl50,95, each recognize subtly different 
residues in order to provide a greater spectrum of target molecules. Talam&s- 
Rohana et al. (98) have shown that the abundant surface glycolipid, lipophos- 
phoglycan (LPG) from Leishmania mexicana promastigotes directly binds to 
members of the CR3, LFA-1, and pl50.95 family of leukocyte integrins by the 
'TPS" binding site. Bullock and Wright (12) have shown that all three
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member of the CR3, LFA-1 and pl50,95 family share the ability to recognize 
Histoplasma capsulatum. Five novel phosphoinositol-sphingolipids have 
been purified from the yeast phase of H. capsulatum (8,9). The sphingolipids 
possess an identical inositol phosphoceramide core. Thus the ligand on H. 
capsulatum, the phosphosugar of its sphingolipids, may also be recognized by 
the 'TPS" binding site of the leukocyte integrins.
Experiments by Rosset al. (74) suggest that CR3 expresses a lectin-like bind­
ing site that is distinct from the C3bi-binding site on the a-subunit. This 
lectin-like binding site may be located on the shared {J-subunit, since all three 
member of this integrin family bind to H. capsulatum. Monosaccharides, (J- 
glucan and yeast mannan failed to block the binding of H. capsulatum to 
macrophages (12). In my own previous studies (see Chapter 2) using monosac­
charides and neoglycoconjugates of bovine serum albumin I was unable to 
block the binding of GBS by mouse peritoneal macrophages. These studies 
suggest the role of phosphosugars as candidates for the lectin-like recognition 
site.
Membrane teichoic add from group B streptococd, lipoteichoic add  (LTA) 
binds to a trypsin-sensitive glycoprotein receptor on human adult buccal epi­
thelial cells due to specific interactions with its glycerolphosphate backbone 
(56). My studies on the binding of GBS by macrophages strongly suggest that 
the ligand on GBS that is recognized by the macrophage receptor is lipotei­
choic add. When macrophages are exposed to soluble LTA prior to GBS, the
I l l
binding of bacteria is reduced. Further, LTA-coated surfaces downmodulate 
the capacity of macrophages to bind GBS.
The site on LTA that is recognized by the macrophage receptor has not 
been determined. I might presume that because the receptors bind to LTA 
that is inserted into GBS membranes, the receptors must bind to the hydro­
philic portion of the molecule that is composed of sugar phosphates. This 
would be consistent with the binding of other bacterial phosphosugar surface 
structures by the leukocyte integrins (12,77,98,116). My studies suggesting 
the role of LTA and the fc integrins in the binding of GBS by murine perito­
neal macrophages offer additional support for the role of this family of recep­
tors in the recognition of extracellular pathogens.
OVERALL DISCUSSION
The receptors and ligands involved in mediating non-opsonic adher­
ence of group B stretococci by murine peritoneal macrophages have been 
explored previously, but not identified. The overall goal of this study was to 
identify and characterize the receptor on the macrophage responsible for 
recognition of the bacteria. My premise is that macrophages are at times 
responsible for cellular defenses in the absence of serum factors such as 
complement components, and before the induction of specific recognition 
molecules, antibodies. Macrophages therefore, must have the ability to distin­
guish self from non-self, independent of soluble molecules. For these studies 
it was necessary to develop adherence assays that could quantify adherence of 
GBS to murine macrophages in order to test various substances for their role 
as inhibitors of binding. I developed two adherence assays, one visual and 
the other an enzyme-linked immunosorbent assay. Adherence results from 
these two assays correlate well. These adherence assays as well as those of 
others show that bacteria do indeed adhere to macrophages under a variety of 
in vitro conditions, suggesting the presence of membrane structures on these 
cells with the ability to recognize complementary structures on the bacterial 
surface. Two groups of macrophage membrane receptors have been impli­
cated in microbial recognition, cell-associated lectins, such as the galactose
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receptor, and the integrins. The strategy of this study was to determine if 
either or both of these molecules was involved in bacterial recognition.
Using the adherence assays developed in Chapter 1 ,1 investigated the 
role of the galactose receptor lectin on the macrophages for binding GBS. 
Methods comparing isogenic strains of GBS with exposed galactose, neura­
m inidase-treated bacteria which exposed capsular galactose, and inhibition 
studies using soluble galactose, BSA-glycoconjugates of galactose as well as 
other monosaccharides failed to prove the involvement of the macrophage 
galactose lectin. The stringency of my assay methods and the exhaustive 
testing using different forms of GBS encourages my findings to dispute other 
investigators who have shown the attachment of GBS via the lectin receptor 
for galactose on the macrophage surface.
I then showed that the mechanism for binding of GBS by macro­
phages, such as temperature (118) and divalent cation dependence (91), 
protease sensitivity (100), fibronectin and phorbol ester enhancement (115) 
and 2-deoxy-D-glucose inhibiton (97) were similiar to those of integrin mole­
cules, especially CR3. The presence of monoclonal antibodies to CR3, in 
downmodulation studies, or as soluble competitors for GBS and macrophage 
monolayers, using the visual assay, or in macrophage suspensions detected by 
flow cytometry yielded similiar degrees of inhibition which would suggest the 
involvement of the receptor for complement component C3bi in the recogni-
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tion of GBS.
Talamas-Rohana^f al. (98) have described two classes of ligands for 
CR3. C3bi and fibrinogen possess the peptide RGD (Arg-Gly-Asp) recognized 
by the a-subunit. The Leishmania lipophosphoglycan and E. coli lipopoly- 
saccharide are recognized by a separate site on CR3 (116). The inability of MAb 
M l/70, which recognizes the C3bi binding site, to block adherence as effective­
ly as MAb M18/2, which recognizes the P-subunit (CD18) common to all 
members of the leucocyte integrin family of receptors, indicates that attach­
ment of GBS may involve a bacterial ligand similiar to the phosphosugars of 
Leishmania and E. coli. My studies using purified membrane teichoic add 
from GBS, lipoteichoic add, as an effective inhibitor of macrophage adher­
ence suggest its role in the adherence of GBS via a site on CD18.
Macrophages recognize GBS in the absence of IgG, complement pro­
teins, or bacterial proteins. This novel mechanism of recognition of a gram- 
positive, extracellular pathogen may thus serve as an initial response of cells 
to baderia, before the generation of specific immunity. Consistent with this 
view are the observations on several LAD patients whose cells lack the 
common P-subunit of CR3, LFA-1 and pl50, 95 and express none of the 
mature on their cells surface (91). These patients suffer from recurrent 
bacterial infections. The basis for the susceptibility of neonates as compared 
with adults to GBS infection still remains an area for speculation. The
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predominant hypothesis for this observation is based on evidence of 
decreased complement levels and function in neonates vs. adults (23).
Reduced levels or function of CR3 in neonatal vs. adult macrophages might 
explain the differential susceptibility of neonates to bacteria whose uptake is 
CR3 dependent.
Note in added proof.
In a recent study by Antal et al. (2), the authors report the role of CR3 in 
the opsonin-independent phagocytosis of heat-killed group B streptococci by 
the mouse macrophage-like cell line, PU5-1.8 (monocytic tumor, BALB/c) and 
resident peritoneal macrophages from BALB/c mice. Downmodulation of 
surface Mac-1 (CR3) on macrophages following adherence to anti-Mac-1- 
(M l/70) or anti-CD18- (M18/2) coated surfaces inhibited uptake of GBS, scored 
by microscopic examination. Soluble anti-Mac-1 inhibited phagocytosis of 
GBS by as much as 50% for both mouse peritoneal macrophages and the 
macrophage cell line, whereas soluble anti-CD18 had no effect.
These data support our own studies with one exception. We report 
that soluble M l 8 /2  (anti-CD18) inhibits the binding of GBS to murine 
peritoneal macrophages almost twice as effectively as soluble M l/70 (anti-Mac- 
D/ suggesting that binding site might be on the p-subunit and GBS adherence 
may be relevant for all members of the leukocyte family of integrins. This
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result may be explained by differences in the cell surface of resident vs. 
thioglycollate-elidted peritoneal macrophages and between heat-killed and 
live bacteria.
Our studies using LTA to inhibit adherence of GBS to macrophages 
suggests a major role for the lectin site on the p-subunit leukocyte integrins 
for the binding of GBS consistent with other studies demonstrating adherence 
of £. coli (116) and Leishmania (98), through their phosphosugars, LPS and 
LPG, respectively. Antal et al. indicate (no data shown) that soluble anti-CD18 
inhibits GBS uptake by human cells but not mouse cells, supporting the role 
of the p-subunit in bacterial adherence. In this recent study, using mouse 
macrophages, the authors postulate that inhibited phagocytosis of GBS may 
involve blocking of a recognition site on CR3 by anti-Mac-1 or may involve 
some antibody-induced inhibition of a general signalling functon of CR3 in 
phagocytosis. Their study does not clearly differentiate these possibilities.
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